CN117004700A - Method for high-throughput sequencing of monoclonal antibody variable region genes, composition and kit used by method - Google Patents
Method for high-throughput sequencing of monoclonal antibody variable region genes, composition and kit used by method Download PDFInfo
- Publication number
- CN117004700A CN117004700A CN202311283506.3A CN202311283506A CN117004700A CN 117004700 A CN117004700 A CN 117004700A CN 202311283506 A CN202311283506 A CN 202311283506A CN 117004700 A CN117004700 A CN 117004700A
- Authority
- CN
- China
- Prior art keywords
- variable region
- chain variable
- region gene
- sequence
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 396
- 239000000203 mixture Substances 0.000 title claims abstract description 80
- 238000000034 method Methods 0.000 title claims abstract description 24
- 238000012165 high-throughput sequencing Methods 0.000 title claims abstract description 16
- 239000002299 complementary DNA Substances 0.000 claims abstract description 160
- 210000004408 hybridoma Anatomy 0.000 claims abstract description 143
- 238000012163 sequencing technique Methods 0.000 claims abstract description 68
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 67
- 238000012408 PCR amplification Methods 0.000 claims abstract description 5
- 238000007405 data analysis Methods 0.000 claims abstract description 3
- 108020004414 DNA Proteins 0.000 claims description 140
- 102000053602 DNA Human genes 0.000 claims description 133
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 51
- 239000012634 fragment Substances 0.000 claims description 23
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 20
- 101100370002 Mus musculus Tnfsf14 gene Proteins 0.000 claims description 15
- 239000002773 nucleotide Substances 0.000 claims description 12
- 125000003729 nucleotide group Chemical group 0.000 claims description 12
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 7
- 238000004458 analytical method Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 238000001514 detection method Methods 0.000 abstract description 4
- 102000039446 nucleic acids Human genes 0.000 abstract description 3
- 108020004707 nucleic acids Proteins 0.000 abstract description 3
- 150000007523 nucleic acids Chemical class 0.000 abstract description 3
- 230000003248 secreting effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 230000003321 amplification Effects 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000004113 cell culture Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000010931 gold Substances 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 4
- 238000007481 next generation sequencing Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000010367 cloning Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 238000010802 RNA extraction kit Methods 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 101100298219 Arabidopsis thaliana POT1B gene Proteins 0.000 description 1
- 102100038117 Centromere protein S Human genes 0.000 description 1
- 102100033674 Centromere protein X Human genes 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 101000884588 Homo sapiens Centromere protein S Proteins 0.000 description 1
- 101000944476 Homo sapiens Centromere protein X Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 108091092328 cellular RNA Proteins 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明公开了包括核酸的测定与检测领域中单克隆抗体可变区基因高通量测序的方法及其所用组合物与试剂盒。本发明所要解决的技术问题是如何提高抗体可变区的测序效率。本发明的单克隆抗体可变区基因高通量测序的方法包括:1)获取分泌单克隆抗体的杂交瘤细胞的cDNA;2)以cDNA为模板,用引物组合物进行PCR扩增,得到PCR产物;引物组合物由重链引物(包含重链上游引物和重链下游引物)和轻链引物(包含轻链上游引物和轻链下游引物)组成;重链下游引物和轻链下游引物的5’端均含有barcode序列;3)将PCR产物混合进行测序;将测序结果进行数据分析,得到单克隆抗体可变区基因的序列。The invention discloses a method for high-throughput sequencing of monoclonal antibody variable region genes in the field of nucleic acid determination and detection, as well as compositions and kits used therein. The technical problem to be solved by the present invention is how to improve the sequencing efficiency of antibody variable regions. The method for high-throughput sequencing of monoclonal antibody variable region genes of the present invention includes: 1) obtaining cDNA of hybridoma cells secreting monoclonal antibodies; 2) using cDNA as a template and using primer compositions to perform PCR amplification to obtain PCR Product; the primer composition consists of a heavy chain primer (including a heavy chain upstream primer and a heavy chain downstream primer) and a light chain primer (including a light chain upstream primer and a light chain downstream primer); 5 of the heavy chain downstream primer and the light chain downstream primer Both ends contain barcode sequences; 3) Mix the PCR products for sequencing; perform data analysis on the sequencing results to obtain the sequence of the monoclonal antibody variable region gene.
Description
技术领域Technical field
本发明涉及包括核酸的测定与检测领域中单克隆抗体可变区基因高通量测序的方法及其所用组合物与试剂盒。The present invention relates to methods for high-throughput sequencing of monoclonal antibody variable region genes in the field of nucleic acid determination and detection, as well as compositions and kits therefor.
背景技术Background technique
杂交瘤细胞技术是应用最广泛且最成熟的抗体制备技术平台。杂交瘤细胞是小鼠骨髓瘤细胞和B淋巴细胞融合而成的细胞。它既具有骨髓瘤细胞无限繁殖的特性,又具有淋巴细胞分泌特异性抗体的能力。尽管杂交瘤细胞具有永生化的特性,但仍然存在抗体分泌量下降或丢失的风险,同时细胞培养过程中的污染或储存细胞不当也会导致抗体的丢失。如果通过测序得到抗体可变区序列,将其构建到表达载体中,通过重组表达即可获得相应抗体。因此,通过测序获得抗体可变区序列是非常重要的,它使得抗体能够以碱基序列的形式进行保存。Hybridoma cell technology is the most widely used and mature antibody preparation technology platform. Hybridoma cells are cells formed by the fusion of mouse myeloma cells and B lymphocytes. It has the characteristics of unlimited reproduction of myeloma cells and the ability of lymphocytes to secrete specific antibodies. Although hybridoma cells have the characteristics of immortalization, there is still a risk of decreased or lost antibody secretion, and contamination during cell culture or improper storage of cells can also lead to loss of antibodies. If the antibody variable region sequence is obtained through sequencing, it is constructed into an expression vector and the corresponding antibody can be obtained through recombinant expression. Therefore, it is very important to obtain the antibody variable region sequence through sequencing, which allows the antibody to be preserved in the form of base sequence.
现有的抗体可变区测序是应用一代测序技术。一代测序是Sanger等在20世纪70年代中期发明的DNA末端终止法测序技术,通过在DNA聚合酶、模板、放射性同位素标记的引物、dNTP和ddNTP的作用下发生延伸反应。由于ddNTP的存在,会形成长度不一的DNA延伸片段,然后采用平板凝胶电泳,用4条电泳道来分离4个反应的所得产物,便可以按顺序读出相应的DNA序列。第一代的Sanger测序技术的优点是:测序读长长,测序用时短,具有较高的准确性等特点。Existing antibody variable region sequencing uses first-generation sequencing technology. First-generation sequencing is a DNA end termination sequencing technology invented by Sanger et al. in the mid-1970s. An extension reaction occurs under the action of DNA polymerase, template, radioactive isotope-labeled primer, dNTP and ddNTP. Due to the presence of ddNTPs, DNA extension fragments of different lengths will be formed. Slab gel electrophoresis is then used to separate the products of the four reactions using four electrophoresis lanes, and the corresponding DNA sequences can be read out in sequence. The advantages of the first-generation Sanger sequencing technology are: long sequencing reads, short sequencing time, and high accuracy.
抗体测序过程首先提取杂交瘤细胞RNA,逆转录为cDNA。以cDNA为模板,使用特异性引物扩增抗体可变区序列,将可变区序列进行一代测序。应用一代测序技术虽然可以满足抗体测序需求,但每一个测序反应仅能完成一个抗体轻链或重链可变区的测序,如果扩增产物测序不成功(如测序结果出现套峰;信号弱,产物测序失败),还需要进行TA克隆。因此应用现有方法测序,不但测序成本高、通量低,而且费时费力,不能满足抗体可变区高通量测序的需求。The antibody sequencing process first extracts hybridoma cell RNA and reverse-transcribes it into cDNA. Using cDNA as a template, specific primers are used to amplify the antibody variable region sequence, and the variable region sequence is sequenced for one generation. Although the application of first-generation sequencing technology can meet the needs of antibody sequencing, each sequencing reaction can only complete the sequencing of one antibody light chain or heavy chain variable region. If the sequencing of the amplified product is unsuccessful (for example, there are overlapping peaks in the sequencing results; the signal is weak, Product sequencing fails), TA cloning is also required. Therefore, the application of existing sequencing methods not only has high sequencing costs and low throughput, but is also time-consuming and labor-intensive, and cannot meet the needs of high-throughput sequencing of antibody variable regions.
随着二代测序技术的发展,测序项目在大大降低了测序成本的同时,还大幅提高了测序速度,并且保持了高准确性,虽然在序列读取长度方面二代测序低于一代测序,但是完全可以满足抗体测序的要求。基于测序技术的革新和对抗体测序通量的需求,急需研发以二代测序为基础的抗体高通量测序方法。With the development of second-generation sequencing technology, sequencing projects have greatly reduced sequencing costs while also greatly increasing sequencing speed and maintaining high accuracy. Although second-generation sequencing is lower than first-generation sequencing in terms of sequence read length, It can fully meet the requirements of antibody sequencing. Based on the innovation of sequencing technology and the demand for antibody sequencing throughput, there is an urgent need to develop high-throughput antibody sequencing methods based on second-generation sequencing.
发明内容Contents of the invention
本发明所要解决的技术问题是如何提高抗体可变区基因的测序效率,降低测序成本。The technical problem to be solved by the present invention is how to improve the sequencing efficiency of antibody variable region genes and reduce sequencing costs.
为了解决上述技术问题,本发明提供了一种单克隆抗体可变区基因高通量测序的方法。In order to solve the above technical problems, the present invention provides a method for high-throughput sequencing of monoclonal antibody variable region genes.
本发明提供的单克隆抗体可变区基因高通量测序的方法,包括以下步骤:The method for high-throughput sequencing of monoclonal antibody variable region genes provided by the invention includes the following steps:
1)获取N种杂交瘤细胞的cDNA,所述N种杂交瘤细胞中每种杂交瘤细胞均分泌一种单克隆抗体,所述N为大于等于2的自然数;1) Obtain cDNA of N hybridoma cells, each of the N hybridoma cells secretes a monoclonal antibody, and N is a natural number greater than or equal to 2;
2)以所述每种杂交瘤细胞的cDNA为模板,分别用重链可变区基因引物组合物和轻链可变区基因引物组合物进行PCR扩增每种杂交瘤细胞分泌的单克隆抗体的重链可变区基因和轻链可变区基因,得到每种杂交瘤细胞分泌的单克隆抗体的重链可变区基因PCR产物和每种杂交瘤细胞分泌的单克隆抗体的轻链可变区基因PCR产物;将N种杂交瘤细胞分泌的单克隆抗体的重链可变区基因PCR产物混合进行测序,获得N种杂交瘤细胞分泌的单克隆抗体的重链可变区基因PCR产物测序结果;将N种杂交瘤细胞分泌的单克隆抗体的轻链可变区基因PCR产物混合进行测序,获得N种杂交瘤细胞分泌的单克隆抗体的轻链可变区基因PCR产物测序结果;2) Using the cDNA of each hybridoma cell as a template, use the heavy chain variable region gene primer composition and the light chain variable region gene primer composition to perform PCR to amplify the monoclonal antibodies secreted by each hybridoma cell. The heavy chain variable region gene and the light chain variable region gene were obtained to obtain the heavy chain variable region gene PCR product of the monoclonal antibody secreted by each hybridoma cell and the light chain of the monoclonal antibody secreted by each hybridoma cell. Variable region gene PCR products; mix and sequence the heavy chain variable region gene PCR products of monoclonal antibodies secreted by N hybridoma cells to obtain the heavy chain variable region gene PCR products of monoclonal antibodies secreted by N hybridoma cells Sequencing results; the PCR products of the light chain variable region genes of the monoclonal antibodies secreted by the N hybridoma cells are mixed and sequenced to obtain the sequencing results of the light chain variable region gene PCR products of the monoclonal antibodies secreted by the N hybridoma cells;
所述重链可变区基因引物组合物由重链可变区基因上游引物和重链可变区基因下游index引物组成,重链可变区基因下游index引物由N种引物组成,每种引物的5’端均含有Barcode序列(序列特异性标签),其余为重链可变区基因特异区段,每种重链可变区基因下游index引物的Barcode序列均不同;The heavy chain variable region gene primer composition is composed of a heavy chain variable region gene upstream primer and a heavy chain variable region gene downstream index primer. The heavy chain variable region gene downstream index primer is composed of N types of primers, each primer The 5' ends of all contain Barcode sequences (sequence-specific tags), and the rest are heavy chain variable region gene-specific segments. The Barcode sequences of the downstream index primers of each heavy chain variable region gene are different;
所述轻链可变区基因引物组合物由轻链可变区基因上游引物和轻链可变区基因下游index引物组成,轻链可变区基因下游index引物由N种引物组成,每种引物的5’端均含有Barcode序列(序列特异性标签),其余为轻链可变区基因特异区段,每种轻链可变区基因下游index引物的Barcode序列均不同;The light chain variable region gene primer composition is composed of a light chain variable region gene upstream primer and a light chain variable region gene downstream index primer. The light chain variable region gene downstream index primer is composed of N types of primers, each primer The 5' ends of all contain Barcode sequences (sequence-specific tags), and the rest are light chain variable region gene-specific segments. The Barcode sequences of the downstream index primers of each light chain variable region gene are different;
3)对2)获得的所述N种杂交瘤细胞分泌的单克隆抗体的重链可变区基因PCR产物测序结果和N种杂交瘤细胞分泌的单克隆抗体的轻链可变区基因PCR产物测序结果进行数据分析,分别得到每种杂交瘤细胞分泌的单克隆抗体可变区基因的序列。3) Sequencing the heavy chain variable region gene PCR product of the monoclonal antibody secreted by the N hybridoma cells obtained in 2) and the light chain variable region gene PCR product of the monoclonal antibody secreted by the N hybridoma cells The sequencing results were analyzed and the sequences of the monoclonal antibody variable region genes secreted by each hybridoma cell were obtained.
本方法中,所述Barcode序列为用于区分不同杂交瘤细胞的抗体重链或轻链的单链DNA。所述Barcode序列可为由8个核苷酸组成的单链DNA。In this method, the Barcode sequence is a single-stranded DNA used to distinguish the antibody heavy chain or light chain of different hybridoma cells. The Barcode sequence may be a single-stranded DNA consisting of 8 nucleotides.
所述Barcode序列具体可为如下:The Barcode sequence can be specifically as follows:
B1、5’-TCGTCATG-3’;B2、5’-GTCAGTCC-3’;B3、5’-CGATTACG-3’;B4、5’-TCTACGAG-3’;B5、5’-TAACGTGC-3’;B6、5’-CGAAGGTT-3’;B7、5’-CACGCATT-3’;B8、5’-TACCAGGT-3’;B9、5’-TTACCGAG-3’;B10、5’-AGTCACCT-3’;B11、5’-TCGCATTC-3’;B12、5’-CATGGTAC-3’;B13、5’-CACGGACT-3’;B14、5’-CTGTAGCA-3’;B15、5’-AGAGCTTG-3’;B16、5’-AGCATAGC-3’;B17、5’-CCTACCAT-3’;B18、5’-GTCGTTGA-3’;B19、5’-TGCGTATC-3’;B20、5’-AGCTAACC-3’;B21、5’-GAACGGTA-3’;B22、5’-GGATTGTC-3’;B23、5’-TACCGTCT-3’;B24、5’-CGAGTATC-3’;B25、5’-TGTACGCT-3’;B26、5’-TCCTCTGA-3’;B27、5’-AGCGTATC-3’;B28、5’-TCATCACC-3’;B29、5’-GACAGTAC-3’;B30、5’-GTCCTTAC-3’;B31、5’-GGAGCAAT-3’;B32、5’-AGGAACAG-3’;B33、5’-CAGTGCTA-3’;B34、5’-CTAGCTAG-3’;B35、5’-TGCAAGCA-3’;B36、5’-CGCATCTA-3’;B37、5’-CGTATCTG-3’;B38、5’-GTAGACCT-3’;B39、5’-CGCCATTA-3’;B40、5’-ATGACACC-3’;B41、5’-CAAGTTGA-3’;B42、5’-TGCTGAAG-3’;B43、5’-ATGACCGT-3’;B44、5’-TGGCGAGA-3’;B45、5’-GCACTTCC-3’;B46、5’-GTTACCGA-3’;B47、5’-GACGTCAC-3’;B48、5’-GTTACAGC-3’;B49、5’-TCGATTGC-3’;B50、5’-GACGATCT-3’;B51、5’-TGACGCTA-3’;B52、5’-ATAACGCG-3’;B53、5’-GATTCACC-3’;B54、5’-GGCAAGTA-3’;B55、5’-GATCTAGC-3’;B56、5’-CATTGCGA-3’;B57、5’-GCTGTACA-3’;B58、5’-TAGCAGCT-3’;B59、5’-AGCGACAT-3’;B60、5’-CATTAGCC-3’;B61、5’-CATCTCCA-3’;B62、5’-GTCATCGT-3’;B63、5’-GGACTTCA-3’;B64、5’-CAGGATCA-3’;B65、5’-GAACGATG-3’;B66、5’-CGACTTGC-3’;B67、5’-GATTCCGT-3’和B68、5’-CCGCTTAC-3’。B1, 5'-TCGTCATG-3'; B2, 5'-GTCAGTCC-3'; B3, 5'-CGATTACG-3'; B4, 5'-TCTACGAG-3'; B5, 5'-TAACGTGC-3'; B6, 5'-CGAAGGTT-3'; B7, 5'-CACGCAT-3'; B8, 5'-TACCAGGT-3'; B9, 5'-TTACCGAG-3'; B10, 5'-AGTCACCT-3'; B11, 5'-TCGCATTC-3'; B12, 5'-CATGGTAC-3'; B13, 5'-CACGGACT-3'; B14, 5'-CTGTAGCA-3'; B15, 5'-AGAGCTTG-3'; B16, 5'-AGCATAGC-3'; B17, 5'-CCTACCAT-3'; B18, 5'-GTCGTTGA-3'; B19, 5'-TGCGTATC-3'; B20, 5'-AGCTAACC-3'; B21, 5'-GAACGGTA-3'; B22, 5'-GGATTGTC-3'; B23, 5'-TACCGTCT-3'; B24, 5'-CGAGTATC-3'; B25, 5'-TGTACGCT-3'; B26, 5'-TCCTCTGA-3'; B27, 5'-AGCGTATC-3'; B28, 5'-TCATCACC-3'; B29, 5'-GACAGTAC-3'; B30, 5'-GTCCTTAC-3'; B31, 5'-GGAGCAAT-3'; B32, 5'-AGGAACAG-3'; B33, 5'-CAGTGCTA-3'; B34, 5'-CTAGCTAG-3'; B35, 5'-TGCAAGCA-3'; B36, 5'-CGCATCTA-3'; B37, 5'-CGTATCTG-3'; B38, 5'-GTAGACCT-3'; B39, 5'-CGCCATTA-3'; B40, 5'-ATGACACC-3'; B41, 5'-CAAGTTGA-3'; B42, 5'-TGCTGAAG-3'; B43, 5'-ATGACCGT-3'; B44, 5'-TGGCGAGA-3'; B45, 5'-GCACTTCC-3'; B46, 5'-GTTACCGA-3'; B47, 5'-GACGTCAC-3'; B48, 5'-GTTACAGC-3'; B49, 5'-TCGATTGC-3'; B50, 5'-GACGATCT-3'; B51, 5'-TGACGCTA-3'; B52, 5'-ATAACGCG-3'; B53, 5'-GATTCACC-3'; B54, 5'-GGCAAGTA-3'; B55, 5'-GATCTAGC-3'; B56, 5'-CATTGCGA-3'; B57, 5'-GCTGTACA-3'; B58, 5'-TAGCAGCT-3'; B59, 5'-AGCGACAT-3'; B60, 5'-CATTAGCC-3'; B61, 5'-CATCTCCA-3'; B62, 5'-GTCATCGT-3'; B63, 5'-GGACTTCA-3'; B64, 5'-CAGGATCA-3'; B65, 5'-GAACGATG-3'; B66, 5'-CGACTTGC-3'; B67, 5'-GATTCCGT-3' and B68, 5'-CCGCTTAC-3'.
本发明中,所述重链可变区基因上游引物为特异结合于所述单克隆抗体的重链信号肽编码基因的单链DNA片段,所述重链可变区基因下游index引物为由所述barcode序列和重链可变区基因特异区段连接而成的单链DNA片段,所述重链可变区基因特异区段为特异结合于所述单克隆抗体的重链信号肽区及恒定区基因的DNA。In the present invention, the heavy chain variable region gene upstream primer is a single-stranded DNA fragment that specifically binds to the heavy chain signal peptide encoding gene of the monoclonal antibody, and the heavy chain variable region gene downstream index primer is composed of the A single-stranded DNA fragment formed by connecting the barcode sequence and a heavy chain variable region gene-specific segment. The heavy chain variable region gene-specific segment specifically binds to the heavy chain signal peptide region and constant of the monoclonal antibody. region of DNA.
本发明中,所述轻链可变区基因上游引物为特异结合于所述单克隆抗体的轻链信号肽编码基因的单链DNA片段,所述轻链可变区基因下游index引物为由所述barcode序列和轻链可变区基因特异区段连接而成的单链DNA片段,所述轻链可变区基因特异区段为特异结合于所述单克隆抗体的轻链信号肽区及恒定区基因的DNA。In the present invention, the light chain variable region gene upstream primer is a single-stranded DNA fragment that specifically binds to the light chain signal peptide encoding gene of the monoclonal antibody, and the light chain variable region gene downstream index primer is composed of A single-stranded DNA fragment formed by connecting the barcode sequence and the light chain variable region gene-specific segment. The light chain variable region gene-specific segment specifically binds to the light chain signal peptide region and constant of the monoclonal antibody. region of DNA.
上述方法中,所述杂交瘤可为大鼠杂交瘤或小鼠杂交瘤。In the above method, the hybridoma may be a rat hybridoma or a mouse hybridoma.
所述大鼠杂交瘤细胞可分泌大鼠抗体。The rat hybridoma cells can secrete rat antibodies.
所述小鼠杂交瘤细胞可分泌小鼠抗体。The mouse hybridoma cells can secrete mouse antibodies.
上述方法中,在一个具体的实施例中,所述引物组合物可为A或B:In the above method, in a specific embodiment, the primer composition can be A or B:
A、所述杂交瘤为大鼠杂交瘤,所述大鼠抗体重链可变区基因引物组合物由大鼠抗体重链可变区基因上游引物和大鼠重链可变区基因下游index引物组成,所述大鼠抗体重链可变区基因上游引物为核苷酸序列分别是序列表中序列17-序列31的15种单链DNA,所述大鼠重链可变区基因下游index引物为核苷酸序列是序列表中序列65的单链DNA;所述大鼠抗体轻链可变区基因引物组合物由大鼠轻链可变区基因上游引物和大鼠轻链可变区基因下游index引物组成,所述大鼠轻链可变区基因上游引物为核苷酸序列分别是序列表中序列1-序列15的15种单链DNA,所述大鼠轻链可变区基因下游index引物为序列表中序列64的单链DNA;A. The hybridoma is a rat hybridoma, and the rat antibody heavy chain variable region gene primer composition consists of a rat antibody heavy chain variable region gene upstream primer and a rat heavy chain variable region gene downstream index primer. Composition, the upstream primer of the rat heavy chain variable region gene is 15 kinds of single-stranded DNA whose nucleotide sequences are sequence 17-sequence 31 in the sequence list, and the downstream index primer of the rat heavy chain variable region gene The nucleotide sequence is the single-stranded DNA of sequence 65 in the sequence list; the rat antibody light chain variable region gene primer composition consists of the rat light chain variable region gene upstream primer and the rat light chain variable region gene The downstream index primer consists of 15 kinds of single-stranded DNA whose nucleotide sequences are sequence 1 to sequence 15 in the sequence list. The upstream primers of the rat light chain variable region gene are 15 kinds of single-stranded DNA. The index primer is the single-stranded DNA of sequence 64 in the sequence list;
B、所述杂交瘤为小鼠杂交瘤,所述小鼠抗体重链可变区基因引物组合物由小鼠抗体重链可变区基因上游引物和小鼠重链可变区基因下游index引物组成,所述小鼠抗体重链可变区基因上游引物为核苷酸序列分别是序列表中序列46-序列60的15种单链DNA,所述小鼠重链可变区基因下游index引物为核苷酸序列是序列表中序列63的单链DNA;所述小鼠抗体轻链可变区基因引物组合物由小鼠轻链可变区基因上游引物和小鼠轻链可变区基因下游index引物组成,所述小鼠轻链可变区基因上游引物为核苷酸序列分别是序列表中序列33-序列44的12种单链DNA,所述小鼠轻链可变区基因下游index引物为序列表中序列62的单链DNA。B. The hybridoma is a mouse hybridoma, and the mouse antibody heavy chain variable region gene primer composition consists of a mouse antibody heavy chain variable region gene upstream primer and a mouse heavy chain variable region gene downstream index primer. Composition, the mouse antibody heavy chain variable region gene upstream primer is 15 kinds of single-stranded DNA whose nucleotide sequences are sequence 46-sequence 60 in the sequence list, and the mouse heavy chain variable region gene downstream index primer The nucleotide sequence is the single-stranded DNA of sequence 63 in the sequence list; the mouse antibody light chain variable region gene primer composition consists of a mouse light chain variable region gene upstream primer and a mouse light chain variable region gene The downstream index primer consists of 12 single-stranded DNAs whose nucleotide sequences are sequence 33-sequence 44 in the sequence list, and the mouse light chain variable region gene downstream primers are The index primer is the single-stranded DNA of sequence 62 in the sequence list.
本发明还提供了扩增单克隆抗体可变区基因的组合物,所述组合物由重链可变区基因引物组合物和轻链可变区基因引物组合物组成,所述重链可变区基因引物组合物由重链可变区基因上游引物和重链可变区基因下游index引物组成,重链可变区基因下游index引物由N种引物组成,每种引物的5’端均含有Barcode序列(序列特异性标签),其余为重链可变区基因特异区段,每种重链可变区基因下游index引物的Barcode序列均不同;所述轻链可变区基因引物组合物由轻链可变区基因上游引物和轻链可变区基因下游index引物组成,轻链可变区基因下游index引物由N种引物组成,每种引物的5’端均含有所述Barcode序列(序列特异性标签),其余为轻链可变区基因特异区段,每种轻链可变区基因下游index引物的Barcode序列均不同。The present invention also provides a composition for amplifying monoclonal antibody variable region genes. The composition is composed of a heavy chain variable region gene primer composition and a light chain variable region gene primer composition. The heavy chain variable region gene primer composition The region gene primer composition consists of a heavy chain variable region gene upstream primer and a heavy chain variable region gene downstream index primer. The heavy chain variable region gene downstream index primer consists of N primers, and the 5' end of each primer contains Barcode sequence (sequence-specific tag), and the rest are heavy chain variable region gene-specific segments. The Barcode sequences of the downstream index primers of each heavy chain variable region gene are different; the light chain variable region gene primer composition is composed of The light chain variable region gene upstream primer and the light chain variable region gene downstream index primer are composed of N types of primers, and the 5' end of each primer contains the Barcode sequence (sequence Specific tag), and the rest are specific segments of the light chain variable region gene. The Barcode sequences of the downstream index primers of each light chain variable region gene are different.
所述组合物中,所述barcode序列为用于区分不同杂交瘤细胞的单链DNA,所述barcode序列为如下68种单链DNA分子中的任一种:B1、5’-TCGTCATG-3’;B2、5’-GTCAGTCC-3’;B3、5’-CGATTACG-3’;B4、5’-TCTACGAG-3’;B5、5’-TAACGTGC-3’;B6、5’-CGAAGGTT-3’;B7、5’-CACGCATT-3’;B8、5’-TACCAGGT-3’;B9、5’-TTACCGAG-3’;B10、5’-AGTCACCT-3’;B11、5’-TCGCATTC-3’;B12、5’-CATGGTAC-3’;B13、5’-CACGGACT-3’;B14、5’-CTGTAGCA-3’;B15、5’-AGAGCTTG-3’;B16、5’-AGCATAGC-3’;B17、5’-CCTACCAT-3’;B18、5’-GTCGTTGA-3’;B19、5’-TGCGTATC-3’;B20、5’-AGCTAACC-3’;B21、5’-GAACGGTA-3’;B22、5’-GGATTGTC-3’;B23、5’-TACCGTCT-3’;B24、5’-CGAGTATC-3’;B25、5’-TGTACGCT-3’;B26、5’-TCCTCTGA-3’;B27、5’-AGCGTATC-3’;B28、5’-TCATCACC-3’;B29、5’-GACAGTAC-3’;B30、5’-GTCCTTAC-3’;B31、5’-GGAGCAAT-3’;B32、5’-AGGAACAG-3’;B33、5’-CAGTGCTA-3’;B34、5’-CTAGCTAG-3’;B35、5’-TGCAAGCA-3’;B36、5’-CGCATCTA-3’;B37、5’-CGTATCTG-3’;B38、5’-GTAGACCT-3’;B39、5’-CGCCATTA-3’;B40、5’-ATGACACC-3’;B41、5’-CAAGTTGA-3’;B42、5’-TGCTGAAG-3’;B43、5’-ATGACCGT-3’;B44、5’-TGGCGAGA-3’;B45、5’-GCACTTCC-3’;B46、5’-GTTACCGA-3’;B47、5’-GACGTCAC-3’;B48、5’-GTTACAGC-3’;B49、5’-TCGATTGC-3’;B50、5’-GACGATCT-3’;B51、5’-TGACGCTA-3’;B52、5’-ATAACGCG-3’;B53、5’-GATTCACC-3’;B54、5’-GGCAAGTA-3’;B55、5’-GATCTAGC-3’;B56、5’-CATTGCGA-3’;B57、5’-GCTGTACA-3’;B58、5’-TAGCAGCT-3’;B59、5’-AGCGACAT-3’;B60、5’-CATTAGCC-3’;B61、5’-CATCTCCA-3’;B62、5’-GTCATCGT-3’;B63、5’-GGACTTCA-3’;B64、5’-CAGGATCA-3’;B65、5’-GAACGATG-3’;B66、5’-CGACTTGC-3’;B67、5’-GATTCCGT-3’和B68、5’-CCGCTTAC-3’。In the composition, the barcode sequence is a single-stranded DNA used to distinguish different hybridoma cells, and the barcode sequence is any one of the following 68 single-stranded DNA molecules: B1, 5'-TCGTCATG-3'. ;B2, 5'-GTCAGTCC-3'; B3, 5'-CGATTACG-3'; B4, 5'-TCTACGAG-3'; B5, 5'-TAACGTGC-3'; B6, 5'-CGAAGGTT-3' ;B7, 5'-CACGCATT-3'; B8, 5'-TACCAGGT-3'; B9, 5'-TTACCGAG-3'; B10, 5'-AGTCACCT-3'; B11, 5'-TCGCATTC-3' ;B12, 5'-CATGGTAC-3'; B13, 5'-CACGGACT-3'; B14, 5'-CTGTAGCA-3'; B15, 5'-AGAGCTTG-3'; B16, 5'-AGCATAGC-3' ;B17, 5'-CCTACCAT-3'; B18, 5'-GTCGTTGA-3'; B19, 5'-TGCGTATC-3'; B20, 5'-AGCTAACC-3'; B21, 5'-GAACGGTA-3' ;B22, 5'-GGATTGTC-3'; B23, 5'-TACCGTCT-3'; B24, 5'-CGAGTATC-3'; B25, 5'-TGTACGCT-3'; B26, 5'-TCCTCTGA-3' ;B27, 5'-AGCGTATC-3'; B28, 5'-TCATCACC-3'; B29, 5'-GACAGTAC-3'; B30, 5'-GTCCTTAC-3'; B31, 5'-GGAGCAAT-3' ;B32, 5'-AGGAACAG-3'; B33, 5'-CAGTGCTA-3'; B34, 5'-CTAGCTAG-3'; B35, 5'-TGCAAGCA-3'; B36, 5'-CGCATCTA-3' ;B37, 5'-CGTATCTG-3'; B38, 5'-GTAGACCT-3'; B39, 5'-CGCCATTA-3'; B40, 5'-ATGACACC-3'; B41, 5'-CAAGTTGA-3' ;B42, 5'-TGCTGAAG-3'; B43, 5'-ATGACCGT-3'; B44, 5'-TGGCGAGA-3'; B45, 5'-GCACTTCC-3'; B46, 5'-GTTACCGA-3' ;B47, 5'-GACGTCAC-3'; B48, 5'-GTTACAGC-3'; B49, 5'-TCGATTGC-3'; B50, 5'-GACGATCT-3'; B51, 5'-TGACGCTA-3' ;B52, 5'-ATAACGCG-3'; B53, 5'-GATTCACC-3'; B54, 5'-GGCAAGTA-3'; B55, 5'-GATCTAGC-3'; B56, 5'-CATTGCGA-3' ;B57, 5'-GCTGTACA-3'; B58, 5'-TAGCAGCT-3'; B59, 5'-AGCGACAT-3'; B60, 5'-CATTAGCC-3'; B61, 5'-CATCTCCA-3' ;B62, 5'-GTCATCGT-3'; B63, 5'-GGACTTCA-3'; B64, 5'-CAGGATCA-3'; B65, 5'-GAACGATG-3'; B66, 5'-CGACTTGC-3' ;B67, 5'-GATTCCGT-3' and B68, 5'-CCGCTTAC-3'.
上文所述扩增单克隆抗体可变区基因的组合物中,所述组合物可为A或B:Among the compositions for amplifying monoclonal antibody variable region genes described above, the composition may be A or B:
A、所述单克隆抗体由大鼠杂交瘤产生,所述重链可变区基因引物组合物由大鼠抗体重链可变区基因上游引物和大鼠重链可变区基因下游index引物组成,所述大鼠抗体重链可变区基因上游引物为核苷酸序列分别是序列表中序列17-序列31的15种单链DNA,所述大鼠重链可变区基因下游index引物为核苷酸序列是序列表中序列65的单链DNA;所述轻链可变区基因引物组合物由大鼠轻链可变区基因上游引物和大鼠轻链可变区基因下游index引物组成,所述大鼠轻链可变区基因上游引物为核苷酸序列分别是序列表中序列1-序列15的15种单链DNA,所述大鼠轻链可变区基因下游index引物为序列表中序列64的单链DNA;A. The monoclonal antibody is produced by a rat hybridoma, and the heavy chain variable region gene primer composition is composed of a rat antibody heavy chain variable region gene upstream primer and a rat heavy chain variable region gene downstream index primer. , the upstream primers of the rat antibody heavy chain variable region gene are 15 single-stranded DNAs whose nucleotide sequences are sequence 17-sequence 31 in the sequence list, and the downstream index primers of the rat heavy chain variable region gene are The nucleotide sequence is the single-stranded DNA of sequence 65 in the sequence list; the light chain variable region gene primer composition consists of a rat light chain variable region gene upstream primer and a rat light chain variable region gene downstream index primer. , the upstream primers of the rat light chain variable region gene are 15 single-stranded DNAs whose nucleotide sequences are sequence 1 to sequence 15 in the sequence list, and the downstream index primers of the rat light chain variable region gene are sequence Single-stranded DNA of sequence 64 in the list;
B、所述单克隆抗体由小鼠杂交瘤产生,所述重链可变区基因引物组合物由小鼠抗体重链可变区基因上游引物和小鼠重链可变区基因下游index引物组成,所述小鼠抗体重链可变区基因上游引物为核苷酸序列分别是序列表中序列46-序列60的15种单链DNA;所述小鼠重链可变区基因下游index引物为核苷酸序列是序列表中序列63的单链DNA;所述轻链可变区基因引物组合物由小鼠轻链可变区基因上游引物和小鼠轻链可变区基因下游index引物组成,所述小鼠轻链可变区基因上游引物为核苷酸序列分别是序列表中序列33-序列44的12种单链DNA;所述小鼠轻链可变区基因下游index引物为序列表中序列62的单链DNA。B. The monoclonal antibody is produced by a mouse hybridoma, and the heavy chain variable region gene primer composition consists of a mouse antibody heavy chain variable region gene upstream primer and a mouse heavy chain variable region gene downstream index primer. , the mouse antibody heavy chain variable region gene upstream primers are 15 kinds of single-stranded DNA whose nucleotide sequences are sequence 46-sequence 60 in the sequence list; the mouse heavy chain variable region gene downstream index primer is The nucleotide sequence is the single-stranded DNA of sequence 63 in the sequence list; the light chain variable region gene primer composition is composed of a mouse light chain variable region gene upstream primer and a mouse light chain variable region gene downstream index primer. , the mouse light chain variable region gene upstream primers are 12 single-stranded DNAs whose nucleotide sequences are sequence 33-sequence 44 in the sequence list; the mouse light chain variable region gene downstream index primers are sequence Single-stranded DNA of sequence 62 in the list.
本发明还提供了一种扩增抗体可变区的试剂盒,含有前文所述的引物组合物。The present invention also provides a kit for amplifying the variable region of an antibody, which contains the primer composition described above.
本发明还提供了前文所述的方法在单克隆抗体可变区基因高通量测序中的应用。The present invention also provides the application of the method described above in high-throughput sequencing of monoclonal antibody variable region genes.
本发明还提供了前文所述的组合物在单克隆抗体可变区基因高通量测序中的应用。The present invention also provides the application of the composition described above in high-throughput sequencing of monoclonal antibody variable region genes.
本发明还提供了前文所述的试剂盒在制备单克隆抗体可变区基因高通量测序产品中的应用。The present invention also provides the application of the aforementioned kit in preparing high-throughput sequencing products of monoclonal antibody variable region genes.
本发明还提供了构建抗体进化树的装置,包括:The invention also provides a device for constructing an antibody evolutionary tree, including:
PCR扩增装置,所述扩增装置用于采用前文所述的组合物对N种杂交瘤细胞分泌的单克隆抗体的可变区基因进行扩增,获得抗体可变区基因扩增产物;所述N为大于等于2的自然数;PCR amplification device, the amplification device is used to amplify the variable region genes of monoclonal antibodies secreted by N hybridoma cells using the aforementioned composition to obtain an antibody variable region gene amplification product; N is a natural number greater than or equal to 2;
测序装置,所述测序装置用于对包括所述抗体可变区基因产物进行测序,获得测序结果;A sequencing device, the sequencing device is used to sequence gene products including the antibody variable region and obtain sequencing results;
分析装置,所述分析装置用于基于所述测序结果,构建所述单克隆抗体的进化树。An analysis device, the analysis device is used to construct an evolutionary tree of the monoclonal antibody based on the sequencing results.
本发明中,所述测序方法可为二代测序(如Illumina-Hiseq法)。In the present invention, the sequencing method may be second-generation sequencing (such as Illumina-Hiseq method).
本发明通过在抗体可变区下游引物上添加不同barcode序列(不同接头)的方式,给每种抗体轻链、重链可变区扩增产物上添加一个专属标签,再将N种抗体的轻链、重链可变区扩增产物混合,对混合扩增产物进行二代测序(Illumina-Hiseq)。将混合产物序列测序结果使用公司自主开发的抗体序列分析软件进行分析,不但一次测序可以得到上百个抗体可变区序列,同时也解决了可变区产物一代测序(sanger法)常常遇到的套峰、产物浓度低测序失败等问题,不再需要进行TA克隆。因此,一次二代测序(NGS)即可得到上百个抗体轻链、重链可变区序列。本发明的测序方法获得的测序结果分析简单、易操作、准确度高,无需再对有问题的结果进行TA克隆,相比传统测序方法,既节省了人力和时间,同时也降低了测序成本。The present invention adds a unique label to the amplification product of each antibody light chain and heavy chain variable region by adding different barcode sequences (different linkers) to the downstream primers of the antibody variable region, and then adds the light chain and heavy chain variable region amplification products of N antibodies. The amplified products of heavy chain and heavy chain variable regions were mixed, and the mixed amplified products were subjected to next-generation sequencing (Illumina-Hiseq). The mixed product sequence sequencing results are analyzed using the company's independently developed antibody sequence analysis software. Not only can hundreds of antibody variable region sequences be obtained in one sequencing, but it also solves the problems often encountered in first-generation sequencing of variable region products (sanger method). Problems such as overlapping peaks and sequencing failure due to low product concentration eliminate the need for TA cloning. Therefore, a single next-generation sequencing (NGS) can obtain hundreds of antibody light chain and heavy chain variable region sequences. The sequencing results obtained by the sequencing method of the present invention are simple to analyze, easy to operate, and highly accurate. There is no need to perform TA cloning of problematic results. Compared with traditional sequencing methods, it not only saves manpower and time, but also reduces sequencing costs.
附图说明Description of the drawings
图1为不同抗体提取RNA后的电泳结果,泳道A1-A5为大鼠抗体,泳道A6-A34为小鼠抗体。Figure 1 shows the electrophoresis results after RNA extraction with different antibodies. Lanes A1-A5 are rat antibodies, and lanes A6-A34 are mouse antibodies.
图2为抗体序列分析程序流程图。Figure 2 is a flow chart of the antibody sequence analysis program.
图3为使用含不同barcode的引物组合物对不同抗体的轻链可变区基因扩增结果。其中泳道A1-A5为大鼠抗体,泳道A6-A34为小鼠抗体。Figure 3 shows the amplification results of light chain variable region genes of different antibodies using primer combinations containing different barcodes. Lanes A1-A5 are rat antibodies, and lanes A6-A34 are mouse antibodies.
图4为使用含不同barcode引物组合物对不同抗体的重链可变区基因扩增结果。其中泳道A1-A5为大鼠抗体,泳道A6-A34为小鼠抗体。Figure 4 shows the amplification results of heavy chain variable region genes of different antibodies using primer combinations containing different barcodes. Lanes A1-A5 are rat antibodies, and lanes A6-A34 are mouse antibodies.
具体实施方式Detailed ways
下面结合具体实施方式对本发明进行进一步的详细描述,给出的实施例仅为了阐明本发明,而不是为了限制本发明的范围。以下提供的实施例可作为本技术领域普通技术人员进行进一步改进的指南,并不以任何方式构成对本发明的限制。The present invention will be described in further detail below in conjunction with specific embodiments. The examples given are only for illustrating the present invention and are not intended to limit the scope of the present invention. The examples provided below can serve as a guide for those of ordinary skill in the art to make further improvements, and do not limit the present invention in any way.
下述实施例中的实验方法,如无特殊说明,均为常规方法,按照本领域内的文献所描述的技术或条件或者按照产品说明书进行。The experimental methods in the following examples, unless otherwise specified, are all conventional methods and are carried out in accordance with the techniques or conditions described in literature in the field or in accordance with product instructions.
下述实施例中所用的材料、试剂等,如无特殊说明,均可从商业途径得到。Materials, reagents, etc. used in the following examples can all be obtained from commercial sources unless otherwise specified.
以下实施例中的定量实验,如无特别说明,均设置三次重复实验。Quantitative experiments in the following examples were repeated three times unless otherwise specified.
本发明中的DNA聚合酶2×TransTaq® High Fidelity (HiFi) PCR SuperMix II(-dye)(北京全式金生物技术有限公司,AS131-21)。电泳检测及产物回收用试剂:琼脂糖(北京全式金生物技术有限公司,GS201-01);核酸染料(全式金,GS101-01);DNA loadingbuffer(全式金,GH101-01);DNA marker(全式金,Trans2K® DNA Marker);EasyPure®Quick Gel Extraction Kit(全式金,EG101-01);动物组织/细胞总RNA提取试剂盒(天根,DP451);细胞培养基:DMEM细胞培养基(Thermofisher,11971025);血清:澳洲胎牛血清(特级)(民海,SA102.01);双抗:Penicillin-Streptomycin (Thermo,15070063);细胞培养瓶T25(Thermo,15070063)。The DNA polymerase in the present invention is 2×TransTaq® High Fidelity (HiFi) PCR SuperMix II(-dye) (Beijing Quanshijin Biotechnology Co., Ltd., AS131-21). Reagents for electrophoresis detection and product recovery: agarose (Beijing Quan-Gold Biotechnology Co., Ltd., GS201-01); nucleic acid dye (Qual-gold, GS101-01); DNA loading buffer (Qual-gold, GH101-01); DNA marker (full gold, Trans2K® DNA Marker); EasyPure®Quick Gel Extraction Kit (full gold, EG101-01); animal tissue/cell total RNA extraction kit (Tiangen, DP451); cell culture medium: DMEM cells Medium (Thermofisher, 11971025); serum: Australian fetal calf serum (special grade) (Minhai, SA102.01); double antibody: Penicillin-Streptomycin (Thermo, 15070063); cell culture flask T25 (Thermo, 15070063).
本文核苷酸序列中,R=A或G,Y=T或C,K=T或G,W=A或T,M=C或A,S=C或G,V=A或C或G,N为A、T、C或G。In the nucleotide sequence of this article, R=A or G, Y=T or C, K=T or G, W=A or T, M=C or A, S=C or G, V=A or C or G , N is A, T, C or G.
实施例1、大鼠、小鼠抗体可变区基因高通量测序的方法建立Example 1. Establishment of high-throughput sequencing method for rat and mouse antibody variable region genes
1、细胞RNA的提取1. Extraction of cellular RNA
培养名称分别为杂交瘤细胞A1-A34的34种杂交瘤细胞,其中,34种杂交瘤细胞中每一种杂交瘤细胞各分泌一种单克隆抗体,其名称分别为抗体A1-A34。其中,杂交瘤细胞A1-A5为大鼠杂交瘤细胞,杂交瘤细胞A6-A34为小鼠杂交瘤细胞。动物细胞培养方法如下:使用T25细胞培养瓶在培养基(1×DMEM+10%胎牛血清+1%双抗)中培养杂交瘤细胞,将细胞培养瓶置于二氧化碳培养箱中,培养条件:37℃,5% CO2。待其长到约5×106-1×107个/瓶,回收细胞。Thirty-four types of hybridoma cells, named hybridoma cells A1-A34, were cultured. Each of the 34 types of hybridoma cells secreted a monoclonal antibody, whose names were antibodies A1-A34. Among them, hybridoma cells A1-A5 are rat hybridoma cells, and hybridoma cells A6-A34 are mouse hybridoma cells. The animal cell culture method is as follows: Use a T25 cell culture bottle to culture hybridoma cells in culture medium (1×DMEM+10% fetal bovine serum+1% double antibody), place the cell culture bottle in a carbon dioxide incubator, and culture conditions: 37℃, 5% CO 2 . When the cells grow to about 5×10 6 -1×10 7 /flask, collect the cells.
采用RNA提取试剂盒从大鼠和小鼠杂交瘤细胞中提取RNA,对提取的RNA进行电泳验证,跑胶观察RNA完整性。结果如图1所示,提取的总RNA存在清晰的28S和18S两条rRNA条带,且28S rRNA条带的强度约为18S rRNA条带的2倍,提示RNA完整性较好。Use an RNA extraction kit to extract RNA from rat and mouse hybridoma cells, conduct electrophoresis verification of the extracted RNA, and run gel to observe the integrity of the RNA. The results are shown in Figure 1. There are two clear rRNA bands of 28S and 18S in the extracted total RNA, and the intensity of the 28S rRNA band is about twice that of the 18S rRNA band, indicating that the RNA integrity is good.
采用SMARTer RACE 5’/3’Kit试剂盒(Clontech,货号634499)逆转录获得杂交瘤细胞的cDNA,分别得到杂交瘤细胞A1-A34的cDNA。SMARTer RACE 5’/3’Kit kit (Clontech, Cat. No. 634499) was used to obtain the cDNA of hybridoma cells by reverse transcription, and the cDNA of hybridoma cells A1-A34 were obtained respectively.
2、大鼠和小鼠抗体轻链可变区基因引物、重链可变区基因引物合成2. Synthesis of light chain variable region gene primers and heavy chain variable region gene primers for rat and mouse antibodies
1)大鼠抗体轻链可变区基因上游引物共15种,具体如下:1) There are 15 types of upstream primers for rat antibody light chain variable region genes, as follows:
(1)RATKF1:5’-RACATTGTSHTGACYCAGTCTC-3’(序列1);(1) RATKF1: 5’-RAATTGTSHTGACYCAGTCTC-3’ (sequence 1);
(2)RATKF2:5’-GAAACTGTGATGACCCAGTC-3’(序列2);(2) RATKF2: 5’-GAAACTGTGATGACCCAGTC-3’ (sequence 2);
(3)RATKF3:5’-CAGGCTGTTGTGACTCAGG-3’(序列3);(3) RATKF3: 5’-CAGGCTGTTGTGACTCAGG-3’ (sequence 3);
(4)RATKF4:5’-RACRTCCAGWTRACCCAGWCT-3’(序列4);(4) RATKF4: 5’-RACRTCCAGWTRACCCAGWCT-3’ (sequence 4);
(5)RATKF5:5’-GACATCCAYATGACWCAGWM-3’(序列5);(5) RATKF5: 5’-GACATCCAYATGACWCAGWM-3’ (sequence 5);
(6)RATKF6:5’-GACATYSRGATGACYMAGTCTC-3’(序列6);(6) RATKF6: 5’-GACATYSRGATGACYMAGTCTC-3’ (sequence 6);
(7)RATKF7:5’-GACATTKYGATRACCCARTMT-3’(序列7);(7) RATKF7: 5’-GACATTKYGATRACCCARTMT-3’ (sequence 7);
(8)RATKF8:5’-GATATTGTGATGACHCARRS-3’(序列8);(8) RATKF8: 5’-GATATTGTGATGACHCARRS-3’ (sequence 8);
(9)RATKF9:5’-GATGTTGTTTTGGTGACACA-3’(序列9);(9) RATKF9: 5’-GATGTTGTTTTTGGTGACACA-3’ (sequence 9);
(10)RATKF10:5’-GATGTTRTGMTGRCCCAGAC-3’(序列10);(10) RATKF10: 5’-GATGTTRTGMTGRCCCAGAC-3’ (sequence 10);
(11)RATKF11:5’-GAMATTRTRCTVACCCAGTCT-3’(序列11);(11) RATKF11: 5’-GAMATTRTRCTVACCCAGTCT-3’ (sequence 11);
(12)RATKF12:5’-GAWAWTGTKCTMMCTCAGTC-3’(序列12);(12) RATKF12: 5’-GAWAWTGTKCTMMCTCAGTC-3’ (sequence 12);
(13)RATKF13:5’-GACGTTGTGCTGACTCAGTC-3’(序列13);(13) RATKF13: 5’-GACGTTGTGCTGACTCAGTC-3’ (sequence 13);
(14)RATKF14:5’-CAGCCCGTGCTGCATCAG-3’(序列14);(14) RATKF14: 5’-CAGCCCGTGCTGCATCAG-3’ (sequence 14);
(15)RATKF15:5’-CAGWTCACGCTSACYCARCM-3’(序列15)。(15) RATKF15: 5’-CAGWTCACGCTSACYCARCM-3’ (sequence 15).
大鼠抗体轻链可变区基因下游引物为index引物,其通用区段(大鼠抗体轻链可变区基因特异区段)为RATKR,具体如下:RATKR:5’—ACGTTTYATTTCCARCTKSGTC-3’(序列16)。The downstream primer of the rat antibody light chain variable region gene is the index primer, and its general section (specific section of the rat antibody light chain variable region gene) is RATKR, as follows: RATKR: 5'-ACGTTTYATTTCCARCTKSGTC-3' (sequence 16).
大鼠抗体重链可变区基因上游引物共15种,具体如下:There are 15 types of upstream primers for rat antibody heavy chain variable region genes, as follows:
(1)RATHF1:5’-GATCAGGTRCARCTRAMRGAGTCAGG-3’(序列17);(1) RATHF1: 5’-GATCAGGTRCARCTRAMRGAGTCAGG-3’ (sequence 17);
(2)RATHF2:5’-GATCAGGTGSAKMTGAAGGAGWC-3’(序列18);(2) RATHF2: 5’-GATCAGGTGSAKMTGAAGGAGWC-3’ (sequence 18);
(3)RATHF3:5’-GATCARGTGCAGYKGAWGGAGTC-3’(序列19);(3)RATHF3: 5’-GATCARGTGCAGYKGAWGGAGTC-3’ (sequence 19);
(4)RATHF4:5’-GATCAGGTHCAGCTGCASCARTCT-3’(序列20);(4) RATHF4: 5’-GATCAGGTHCAGCTGCASCARTCT-3’ (sequence 20);
(5)RATHF5:5’-GATCAGATCCAGTTGGYACAGTC-3’(序列21);(5) RATHF5: 5’-GATCAGATCCAGTTGGYACAGTC-3’ (sequence 21);
(6)RATHF6:5’-GATCAGGCCCAGCTGCAGTCTGG-3’(序列22);(6) RATHF6: 5’-GATCAGGCCCAGCTGCAGTCTGG-3’ (sequence 22);
(7)RATHF7:5’-GATCAGGTCCAGYTGCAGCARTS-3’(序列23);(7) RATHF7: 5’-GATCAGGTCCAGYTGCAGCARTS-3’ (sequence 23);
(8)RATHF8:5’-GATCAGATTCAGCTGCARCAGTG-3’(序列24);(8) RATHF8: 5’-GATCAGATTCAGCTGCARCAGTG-3’ (sequence 24);
(9)RATHF9:5’-GATCAAACAGTCCAGCTACAGCAGTC-3’(序列25);(9) RATHF9: 5’-GATCAAACAGTCCAGCTACAGCAGTC-3’ (sequence 25);
(10)RATHF10:5’-GATCAAGARGTCCWGCTGCAKCAGTM-3’(序列26);(10) RATHF10: 5’-GATCAAGARGTCCWGCTGCAKCAGTM-3’ (sequence 26);
(11)RATHF11:5’-GATCAGGTTMMTCTGMAASAGTC-3’(序列27);(11) RATHF11: 5’-GATCAGGTTMMCTGMAASAGTC-3’ (sequence 27);
(12)RATHF12:5’-GATCARGTYAASCTRCWGCAGTC-3’(序列28);(12)RATHF12: 5’-GATCARGTYAASCTRCWGCAGTC-3’ (sequence 28);
(13)RATHF13:5’-GATCAAGAGGTAAAGCTGCARCAGTC-3’(序列29);(13) RATHF13: 5’-GATCAAGAGGTAAAGCTGCARCAGTC-3’ (sequence 29);
(14)RATHF14:5’-GATCAAGARGTTCARCTGCAGCAGTC-3’(序列30);(14) RATHF14: 5’-GATCAAGARGTTCARCTGCAGCAGTC-3’ (sequence 30);
(15)RATHF15:5’-GATCAAGAGGTGCARMTTCWGGAGWC-3’(序列31)。(15) RATHF15: 5’-GATCAAGAGGTGCARMTTCWGGAGWC-3’ (sequence 31).
大鼠抗体重链可变区基因下游引物为index引物,其通用区段(大鼠抗体重链可变区基因特异区段)为RATHR,具体如下:RATHR:5’-GATCKGAGGASACGGTGACCRKGG-3’(序列32)。The downstream primer of the rat antibody heavy chain variable region gene is the index primer, and its general section (specific section of the rat antibody heavy chain variable region gene) is RATHR, specifically as follows: RATHR: 5'-GATCKGAGGASACGGTGACCRKGG-3' (sequence 32).
小鼠抗体轻链可变区基因上游引物共12种,具体如下:There are 12 types of upstream primers for mouse antibody light chain variable region genes, as follows:
(1)MKF1:5’-GCTTACAGGTGCCAGATGT-3’(序列33);(1) MKF1: 5’-GCTTACAGGTGCCAGATGT-3’ (sequence 33);
(2)MKF2:5’-TCAATTGTAGRTGCCAGATGT-3’(序列34);(2) MKF2: 5’-TCAATTGTAGRTGCCAGATGT-3’ (sequence 34);
(3)MKF3:5’-TTACAGTAGGTGTCAGATGT-3’(序列35);(3) MKF3: 5’-TTACAGTAGGTGTCAGATGT-3’ (sequence 35);
(4)MKF4:5’-CAGTCGTAGTTGTCAGATGT-3’(序列36);(4) MKF4: 5’-CAGTCGTAGTTGTCAGATGT-3’ (sequence 36);
(5)MKF5:5’-CCTCCTTCTTGGCCAAGA-3’(序列37);(5) MKF5: 5’-CCTCCTCTTGGCCAAGA-3’ (sequence 37);
(6)MKF6:5’-TTATATGGAGCTGATGGG-3’(序列38);(6) MKF6: 5’-TTATATGGAGCTGATGGG-3’ (sequence 38);
(7)MKF7:5’-GTGTCTGGTGCTCATGGG-3’(序列39);(7) MKF7: 5’-GTGTCTGGTGCTCATGGG-3’ (sequence 39);
(8)MKF8:5’-CTSTGGTTGTCTGGTGTTGA-3’(序列40);(8) MKF8: 5’-CTSTGGTTGTCTGGTGTTGA-3’ (sequence 40);
(9)MKF9:5’-GTCTCTGATTCTAGGGCA-3’(序列41);(9) MKF9: 5’-GTCTCTGATTCTAGGGCA-3’ (sequence 41);
(10)MKF10:5’-TGCTKCKCTGGGTTCCAG-3’(序列42);(10) MKF10: 5’-TGCTKCKCTGGGTTCCAG-3’ (sequence 42);
(11)MKF11:5’-TTGCAGGTGTTGACGGA-3’(序列43);(11) MKF11: 5’-TTGCAGGTGTTGACGGA-3’ (sequence 43);
(12)MKF12:5’-GTAGGTGCCTCGTGCAC-3’(序列44)。(12) MKF12: 5’-GTAGGTGCCTCGTGCAC-3’ (sequence 44).
小鼠抗体轻链可变区基因下游引物为index引物,其通用区段(小鼠抗体轻链可变区基因特异区段)为MKR,具体如下:MKR:5’-CGACTAGTCGACTGGTGGGAAGATGGATACAG-3’(序列45)。The downstream primer of the mouse antibody light chain variable region gene is the index primer, and its universal segment (specific segment of the mouse antibody light chain variable region gene) is MKR, specifically as follows: MKR: 5'-CGACTAGTCGACTGGTGGGAAGATGGATACAG-3' (sequence 45).
小鼠抗体重链可变区基因上游引物共15种,具体如下:There are 15 types of upstream primers for mouse antibody heavy chain variable region genes, as follows:
(1)MHF1:5’-ACTGCAGGTRTCCACTCC-3’(序列46);(1) MHF1:5’-ACTGCAGGTRTCCACTCC-3’ (sequence 46);
(2)MHF2:5’-RCTACAGGTGTCCACTCC-3’(序列47);(2) MHF2:5’-RCTACAGGTGTCCACTCC-3’ (sequence 47);
(3)MHF3:5’-ACTGCAGGTGTCCWMTCC-3’(序列48);(3) MHF3:5’-ACTGCAGGTGTCCWMTCC-3’ (sequence 48);
(4)MHF4:5’-RCTRCAGGTGTKCACTCC-3’(序列49);(4) MHF4:5’-RCTRCAGGTGTKCACTCC-3’ (sequence 49);
(5)MHF5:5’-GCTACAGGTGCTCACTCC-3’(序列50);(5) MHF5:5’-GCTACAGGTGCTCACTCC-3’ (sequence 50);
(6)MHF6:5’-AYTGCAGGTGTCCAYTGC-3’(序列51);(6) MHF6:5’-AYTGCAGGTGTCCAYTGC-3’ (sequence 51);
(7)MHF7:5’-GCTAMMGGTGTCCACTTC-3’(序列52);(7) MHF7:5’-GCTAMMGGTGTCCACTTC-3’ (sequence 52);
(8)MHF8:5’-RCTRCAGGYGTCCACTCT-3’(序列53);(8) MHF8:5’-RCTRCAGGYGTCCACTCT-3’ (sequence 53);
(9)MHF9:5’-CCAAGCTGTATCCTTTCC-3’(序列54);(9) MHF9:5’-CCAAGCTGTATCCTTTCC-3’ (sequence 54);
(10)MHF10:5’-CCAAGCTGTGTCCTRTCC-3’(序列55);(10) MHF10:5’-CCAAGCTGTGTCCTRTCC-3’ (sequence 55);
(11)MHF11:5’-GTTTTAAAAGGTGTCCTGTG-3’(序列56);(11) MHF11:5’-GTTTTAAAAGGTGTCCTGTG-3’ (sequence 56);
(12)MHF12:5’-CTYTTAAAAGGKGTCCAGWG-3’(序列57);(12) MHF12:5’-CTYTTAAAAGGKGTCCAGWG-3’ (sequence 57);
(13)MHF13:5’-CYTTTAMATGGTATCCAGTGT-3’(序列58);(13) MHF13:5’-CYTTTAMATGGTATCCAGTGT-3’ (sequence 58);
(14)MHF14:5’-CTTTTACATGGTTTCAAGTGT-3’(序列59);(14) MHF14:5’-CTTTTACATGGTTTCAAGTGT-3’ (sequence 59);
(15)MHF15:5’-YTGTCCCTGCATATGTCYT-3’(序列60)。(15) MHF15:5’-YTGTCCCTGCATATGTCYT-3’ (sequence 60).
小鼠抗体重链可变区基因下游引物为index引物,其通用区段(小鼠抗体重链可变区基因特异区段)为MHR,具体如下:MHR:5’-GGATAGACWGATGGGGSTGTYGTT-3’(序列61)。The downstream primer of the mouse antibody heavy chain variable region gene is the index primer, and its general section (specific section of the mouse antibody heavy chain variable region gene) is MHR, as follows: MHR:5'-GGATAGACWGATGGGGSTGTYGTT-3' (sequence 61).
3、Barcode序列及index引物合成3. Barcode sequence and index primer synthesis
重链可变区基因下游index引物和轻链可变区基因下游index引物的5’端均含有Barcode序列,其余为通用区段。Barcode序列为用于区分不同抗体重链或轻链的单链DNA。本实施例中,Barcode序列为由8个核苷酸组成的单链DNA。The 5’ end of the index primer downstream of the heavy chain variable region gene and the index primer downstream of the light chain variable region gene both contain Barcode sequences, and the rest are universal segments. Barcode sequences are single-stranded DNA used to distinguish between different antibody heavy or light chains. In this embodiment, the Barcode sequence is a single-stranded DNA composed of 8 nucleotides.
1)Barcode序列合成1) Barcode sequence synthesis
本发明给出了B1-B68的68种Barcode序列,具体见如下:B1、5’-TCGTCATG-3';B2、5’-GTCAGTCC-3’;B3、5’-CGATTACG-3’;B4、5’-TCTACGAG-3’;B5、5’-TAACGTGC-3’;B6、5’-CGAAGGTT-3’;B7、5’-CACGCATT-3’;B8、5’-TACCAGGT-3’;B9、5’-TTACCGAG-3’;B10、5’-AGTCACCT-3’;B11、5’-TCGCATTC-3’;B12、5’-CATGGTAC-3’;B13、5’-CACGGACT-3’;B14、5’-CTGTAGCA-3’;B15、5’-AGAGCTTG-3’;B16、5’-AGCATAGC-3’;B17、5’-CCTACCAT-3’;B18、5’-GTCGTTGA-3’;B19、5’-TGCGTATC-3’;B20、5’-AGCTAACC-3’;B21、5’-GAACGGTA-3’;B22、5’-GGATTGTC-3’;B23、5’-TACCGTCT-3’;B24、5’-CGAGTATC-3’;B25、5’-TGTACGCT-3’;B26、5’-TCCTCTGA-3’;B27、5’-AGCGTATC-3’;B28、5’-TCATCACC-3’;B29、5’-GACAGTAC-3’;B30、5’-GTCCTTAC-3’;B31、5’-GGAGCAAT-3’;B32、5’-AGGAACAG-3’;B33、5’-CAGTGCTA-3’;B34、5’-CTAGCTAG-3’;B35、5’-TGCAAGCA-3’;B36、5’-CGCATCTA-3’;B37、5’-CGTATCTG-3’;B38、5’-GTAGACCT-3’;B39、5’-CGCCATTA-3’;B40、5’-ATGACACC-3’;B41、5’-CAAGTTGA-3’;B42、5’-TGCTGAAG-3’;B43、5’-ATGACCGT-3’;B44、5’-TGGCGAGA-3’;B45、5’-GCACTTCC-3’;B46、5’-GTTACCGA-3’;B47、5’-GACGTCAC-3’;B48、5’-GTTACAGC-3’;B49、5’-TCGATTGC-3’;B50、5’-GACGATCT-3’;B51、5’-TGACGCTA-3’;B52、5’-ATAACGCG-3’;B53、5’-GATTCACC-3’;B54、5’-GGCAAGTA-3’;B55、5’-GATCTAGC-3’;B56、5’-CATTGCGA-3’;B57、5’-GCTGTACA-3’;B58、5’-TAGCAGCT-3’;B59、5’-AGCGACAT-3’;B60、5’-CATTAGCC-3’;B61、5’-CATCTCCA-3’;B62、5’-GTCATCGT-3’;B63、5’-GGACTTCA-3’;B64、5’-CAGGATCA-3’;B65、5’-GAACGATG-3’;B66、5’-CGACTTGC-3’;B67、5’-GATTCCGT-3’和B68、5’-CCGCTTAC-3’,由通用生物合成。The present invention provides 68 kinds of Barcode sequences of B1-B68, specifically as follows: B1, 5'-TCGTCATG-3'; B2, 5'-GTCAGTCC-3'; B3, 5'-CGATTACG-3'; B4, 5'-TCTACGAG-3'; B5, 5'-TAACGTGC-3'; B6, 5'-CGAAGGTT-3'; B7, 5'-CACGCAT-3'; B8, 5'-TACCAGGT-3'; B9, 5'-TTACCGAG-3'; B10, 5'-AGTCACCT-3'; B11, 5'-TCGCATTC-3'; B12, 5'-CATGGTAC-3'; B13, 5'-CACGGACT-3'; B14, 5'-CTGTAGCA-3'; B15, 5'-AGAGCTTG-3'; B16, 5'-AGCATAGC-3'; B17, 5'-CCTACCAT-3'; B18, 5'-GTCGTTGA-3'; B19, 5'-TGCGTATC-3'; B20, 5'-AGCTAACC-3'; B21, 5'-GAACGGTA-3'; B22, 5'-GGATTGTC-3'; B23, 5'-TACCGTCT-3'; B24, 5'-CGAGTATC-3'; B25, 5'-TGTACGCT-3'; B26, 5'-TCCTCTGA-3'; B27, 5'-AGCGTATC-3'; B28, 5'-TCATCACC-3'; B29, 5'-GACAGTAC-3'; B30, 5'-GTCCTTAC-3'; B31, 5'-GGAGCAAT-3'; B32, 5'-AGGAACAG-3'; B33, 5'-CAGTGCTA-3'; B34, 5'-CTAGCTAG-3'; B35, 5'-TGCAAGCA-3'; B36, 5'-CGCATCTA-3'; B37, 5'-CGTATCTG-3'; B38, 5'-GTAGACCT-3'; B39, 5'-CGCCATTA-3'; B40, 5'-ATGACACC-3'; B41, 5'-CAAGTTGA-3'; B42, 5'-TGCTGAAG-3'; B43, 5'-ATGACCGT-3'; B44, 5'-TGGCGAGA-3'; B45, 5'-GCACTTCC-3'; B46, 5'-GTTACCGA-3'; B47, 5'-GACGTCAC-3'; B48, 5'-GTTACAGC-3'; B49, 5'-TCGATTGC-3'; B50, 5'-GACGATCT-3'; B51, 5'-TGACGCTA-3'; B52, 5'-ATAACGCG-3'; B53, 5'-GATTCACC-3'; B54, 5'-GGCAAGTA-3'; B55, 5'-GATCTAGC-3'; B56, 5'-CATTGCGA-3'; B57, 5'-GCTGTACA-3'; B58, 5'-TAGCAGCT-3'; B59, 5'-AGCGACAT-3'; B60, 5'-CATTAGCC-3'; B61, 5'-CATCTCCA-3'; B62, 5'-GTCATCGT-3'; B63, 5'-GGACTTCA-3'; B64, 5'-CAGGATCA-3'; B65, 5'-GAACGATG-3'; B66, 5'-CGACTTGC-3'; B67, 5'-GATTCCGT-3' and B68, 5'-CCGCTTAC-3', by Generic Biosynthesis.
2)index引物合成2) Index primer synthesis
通过在抗体重链可变区基因下游引物或轻链可变区基因下游引物的5’端加入上述步骤1)中的barcode序列合成index引物。不同barcode序列可作为标签对一种抗体轻链或重链进行标记,即一种barcode序列与一种抗体轻链或重链可变区基因序列是一一对应的关系。步骤1)提供了68种Barcode,index引物设计具体如下:Synthesize the index primer by adding the barcode sequence in step 1) above to the 5' end of the antibody heavy chain variable region gene downstream primer or the light chain variable region gene downstream primer. Different barcode sequences can be used as tags to mark an antibody light chain or heavy chain, that is, there is a one-to-one correspondence between a barcode sequence and an antibody light chain or heavy chain variable region gene sequence. Step 1) 68 kinds of Barcodes are provided, and the index primer design is as follows:
A、小鼠抗体轻链可变区基因下游index引物:A. Index primer downstream of mouse antibody light chain variable region gene:
在小鼠抗体轻链的下游引物通用区段MKR的5’端加入barcode序列合成小鼠抗体轻链可变区基因下游index引物:5’-NNNNNNNNCGACTAGTCGACTGGTGGGAAGATGGATACAG-3’(序列表中序列62)。序列62的第1-8位(5’-NNNNNNNN-3’)为Barcode,68种Barcode的核苷酸序列具体见上述步骤1)。本步骤使用上述步骤1)中的B1-B29共29种不同barcode序列,得到29条小鼠抗体轻链可变区基因下游index引物。Add the barcode sequence to the 5' end of the universal segment MKR of the downstream primer of the mouse antibody light chain to synthesize the downstream index primer of the mouse antibody light chain variable region gene: 5'-NNNNNNNNCGACTAGTCGACTGGTGGGAAGATGGATACAG-3' (sequence 62 in the sequence listing). Positions 1-8 (5’-NNNNNNNN-3’) of sequence 62 are Barcodes. For the nucleotide sequences of the 68 Barcodes, see step 1) above. This step uses a total of 29 different barcode sequences from B1 to B29 in step 1) above to obtain 29 mouse antibody light chain variable region gene downstream index primers.
B、小鼠抗体重链可变区基因下游index引物:B. Index primer downstream of mouse antibody heavy chain variable region gene:
在小鼠抗体重链的下游引物通用区段MHR的5’端加入barcode序列合成小鼠抗体重链可变区基因下游index引物:5’-NNNNNNNNGGATAGACWGATGGGGSTGTYGTT-3’(序列表中序列63)。序列63的第1-8位(5’-NNNNNNNN-3’)为Barcode,本步骤使用上述步骤1)中的B30-B58共29种不同barcode序列,得到含不同barcode序列的29条小鼠抗体重链可变区基因下游index引物。Add the barcode sequence to the 5' end of the universal segment MHR of the downstream primer of the mouse antibody heavy chain to synthesize the downstream index primer of the mouse antibody heavy chain variable region gene: 5'-NNNNNNNNGGATAGACWGATGGGGSTGTYGTT-3' (sequence 63 in the sequence listing). Positions 1-8 (5'-NNNNNNNN-3') of sequence 63 are Barcodes. This step uses a total of 29 different barcode sequences from B30-B58 in step 1) above to obtain 29 mouse antibodies containing different barcode sequences. Index primer downstream of the heavy chain variable region gene.
C、大鼠抗体轻链可变区基因下游index引物:C. Index primer downstream of rat antibody light chain variable region gene:
在大鼠抗体轻链的下游引物通用区段RATKR的5’端加入barcode序列合成大鼠抗体轻链可变区基因下游index引物:5’-NNNNNNNNACGTTTYATTTCCARCTKSGTC-3’(序列表中序列64)。序列64的第1-8位(5’-NNNNNNNN-3’)为Barcode,68种Barcode的核苷酸序列具体见上述步骤1)。本步骤使用上述步骤1)中的B59-B63共5种不同barcode序列,得到含不同barcode序列的5条大鼠抗体轻链可变区基因下游index引物。Add the barcode sequence to the 5' end of the universal segment RATKR of the downstream primer of the rat antibody light chain to synthesize the downstream index primer of the rat antibody light chain variable region gene: 5'-NNNNNNNNACGTTTYATTTCCARCTKSGTC-3' (sequence 64 in the sequence listing). Positions 1-8 (5’-NNNNNNNN-3’) of sequence 64 are Barcodes. For the nucleotide sequences of the 68 Barcodes, see step 1) above. This step uses a total of 5 different barcode sequences from B59-B63 in step 1) above to obtain 5 downstream index primers for rat antibody light chain variable region genes containing different barcode sequences.
D、大鼠抗体重链可变区基因下游index引物:D. Index primer downstream of rat antibody heavy chain variable region gene:
在大鼠抗体重链的下游引物通用区段RATHR的5’端加入barcode序列合成大鼠抗体重链可变区基因下游index引物:5’-NNNNNNNNGATCKGAGGASACGGTGACCRKGG-3’(序列表中序列65)。序列65的第1-8位(5’-NNNNNNNN-3’)为Barcode,68种Barcode的核苷酸序列具体见上述步骤1)。本步骤使用上述步骤1)中的B64-B68共5种不同barcode序列,得到含不同barcode序列的5条大鼠抗体重链可变区基因下游index引物。Add the barcode sequence to the 5' end of the universal section RATHR of the downstream primer of the rat antibody heavy chain to synthesize the downstream index primer of the rat antibody heavy chain variable region gene: 5'-NNNNNNNNGATCKGAGGASACGGTGACCRKGG-3' (sequence 65 in the sequence listing). Positions 1-8 (5’-NNNNNNNN-3’) of sequence 65 are Barcodes. For the nucleotide sequences of the 68 Barcodes, see step 1) above. This step uses a total of 5 different barcode sequences from B64 to B68 in step 1) above to obtain 5 downstream index primers for rat antibody heavy chain variable region genes containing different barcode sequences.
4、大鼠、小鼠抗体可变区高通量测序方法建立4. Establishment of high-throughput sequencing methods for rat and mouse antibody variable regions
1)扩增引物的混合1) Mixing of amplification primers
溶解引物前使用离心机将步骤2和3中获得的引物粉末离心,12000rpm,10min。使用无酶水溶解。Before dissolving the primers, use a centrifuge to centrifuge the primer powder obtained in steps 2 and 3 at 12,000 rpm for 10 minutes. Use enzyme-free water for dissolution.
将步骤2的大鼠抗体轻链可变区基因上游引物共15种混合,得到LR mix,LR mix中,每种大鼠抗体轻链可变区基因上游引物的含量为10μmol/L。Mix a total of 15 types of upstream primers for the rat antibody light chain variable region gene in step 2 to obtain an LR mix. In the LR mix, the content of each type of upstream primer for the rat antibody light chain variable region gene is 10 μmol/L.
将步骤2的大鼠抗体重链可变区基因上游引物共15种混合,得到HR mix,HR mix中,每种大鼠抗体重链可变区基因上游引物的含量为10μmol/L。Mix a total of 15 types of upstream primers for the rat antibody heavy chain variable region gene in Step 2 to obtain an HR mix. In the HR mix, the content of each upstream primer for the rat antibody heavy chain variable region gene is 10 μmol/L.
将步骤2的小鼠抗体轻链可变区基因上游引物共12种混合,得到LM mix,LM mix中,每种小鼠抗体轻链可变区基因上游引物的含量为10μmol/L。Mix a total of 12 types of mouse antibody light chain variable region gene upstream primers from step 2 to obtain LM mix. In the LM mix, the content of each mouse antibody light chain variable region gene upstream primer is 10 μmol/L.
将步骤2的小鼠抗体重链可变区基因上游引物共15种混合,得到HM mix,HM mix中,每种小鼠抗体重链可变区基因上游引物的含量为10μmol/L。Mix a total of 15 types of mouse antibody heavy chain variable region gene upstream primers from step 2 to obtain HM mix. In the HM mix, the content of each mouse antibody heavy chain variable region gene upstream primer is 10 μmol/L.
2)PCR扩增反应2) PCR amplification reaction
A、抗体重链可变区基因PCR体系:A. Antibody heavy chain variable region gene PCR system:
大鼠抗体重链可变区基因PCR体系和小鼠抗体重链可变区PCR体系的区别仅在于:cDNA模板、上游引物和下游index引物不同,其余均相同。The only difference between the rat antibody heavy chain variable region gene PCR system and the mouse antibody heavy chain variable region PCR system is that the cDNA template, upstream primer and downstream index primer are different, and the rest are the same.
大鼠抗体重链可变区基因PCR体系共5个PCR体系,这5个PCR体系分别命名为A1大鼠抗体重链可变区基因PCR体系、A2大鼠抗体重链可变区基因PCR体系、A3大鼠抗体重链可变区基因PCR体系、A4大鼠抗体重链可变区基因PCR体系和A5大鼠抗体重链可变区基因PCR体系。这5个PCR体系的上游引物均为HR mix;这5个PCR体系的cDNA和下游index引物均不同,其中:A1大鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A1的cDNA,下游index引物含有的Barcode序列为B1、5'-TCGTCATG-3’,A2大鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A2的cDNA,下游index引物含有的Barcode序列为B2、5’-GTCAGTCC-3’,A3大鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A3的cDNA,下游index引物含有的Barcode序列为B3、5’-CGATTACG-3’,A4大鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A4的cDNA,下游index引物含有的Barcode序列为B4、5’-TCTACGAG-3’,A5大鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A5的cDNA,下游index引物含有的Barcode序列为B5、5’-TAACGTGC-3’。The rat antibody heavy chain variable region gene PCR system has a total of 5 PCR systems. These 5 PCR systems are named A1 rat antibody heavy chain variable region gene PCR system and A2 rat antibody heavy chain variable region gene PCR system. , A3 rat antibody heavy chain variable region gene PCR system, A4 rat antibody heavy chain variable region gene PCR system and A5 rat antibody heavy chain variable region gene PCR system. The upstream primers of these five PCR systems are all HR mix; the cDNA and downstream index primers of these five PCR systems are all different, among which: the cDNA in the A1 rat antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A1 , the Barcode sequence contained in the downstream index primer is B1, 5'-TCGTCATG-3', the cDNA in the A2 rat antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A2, and the Barcode sequence contained in the downstream index primer is B2 , 5'-GTCAGTCC-3', A3 The cDNA in the rat antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A3, and the Barcode sequence contained in the downstream index primer is B3, 5'-CGATTACG-3', A4 The cDNA in the rat antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A4. The Barcode sequence contained in the downstream index primer is B4, 5'-TCTACGAG-3', and the A5 rat antibody heavy chain variable region PCR system The cDNA in is the cDNA of hybridoma cell A5, and the Barcode sequence contained in the downstream index primer is B5, 5'-TAACGTGC-3'.
大鼠抗体重链可变区基因PCR体系:步骤1中A1-A5杂交瘤细胞中的1种杂交瘤细胞的cDNA 1μL,大鼠抗体重链上游引物(HR mix)1μL,下游index引物(含有特异性的Barcode序列与不同杂交瘤细胞的cDNA一一对应)1μL,2×Trans Taq HiFi PCR Super Mix Ⅱ 5μL,ddH2O 2μL,总体积为10μL。Rat antibody heavy chain variable region gene PCR system: 1 μL of cDNA from one of the A1-A5 hybridoma cells in step 1, 1 μL of rat antibody heavy chain upstream primer (HR mix), and downstream index primer (containing The specific Barcode sequence corresponds to the cDNA of different hybridoma cells one-to-one) 1 μL, 2×Trans Taq HiFi PCR Super Mix II 5 μL, ddH 2 O 2 μL, the total volume is 10 μL.
小鼠抗体重链可变区基因PCR体系共29个PCR体系,这5个PCR体系分别命名为A6小鼠抗体重链可变区基因PCR体系、A7小鼠抗体重链可变区基因PCR体系、A8小鼠抗体重链可变区基因PCR体系、A9小鼠抗体重链可变区基因PCR体系、A10小鼠抗体重链可变区基因PCR体系、A11小鼠抗体重链可变区基因PCR体系、A12小鼠抗体重链可变区基因PCR体系、A13小鼠抗体重链可变区基因PCR体系、A14小鼠抗体重链可变区基因PCR体系、A15小鼠抗体重链可变区基因PCR体系、A16小鼠抗体重链可变区基因PCR体系、A17小鼠抗体重链可变区基因PCR体系、A18小鼠抗体重链可变区基因PCR体系、A19小鼠抗体重链可变区基因PCR体系、A20小鼠抗体重链可变区基因PCR体系、A21小鼠抗体重链可变区基因PCR体系、A22小鼠抗体重链可变区基因PCR体系、A23小鼠抗体重链可变区基因PCR体系、A24小鼠抗体重链可变区基因PCR体系、A25小鼠抗体重链可变区基因PCR体系、A26小鼠抗体重链可变区基因PCR体系、A27小鼠抗体重链可变区基因PCR体系、A28小鼠抗体重链可变区基因PCR体系、A29小鼠抗体重链可变区基因PCR体系、A30小鼠抗体重链可变区基因PCR体系、A31小鼠抗体重链可变区基因PCR体系、A32小鼠抗体重链可变区基因PCR体系、A33小鼠抗体重链可变区基因PCR体系、A34小鼠抗体重链可变区基因PCR体系。The mouse antibody heavy chain variable region gene PCR system has a total of 29 PCR systems. These 5 PCR systems are named A6 mouse antibody heavy chain variable region gene PCR system and A7 mouse antibody heavy chain variable region gene PCR system. , A8 mouse antibody heavy chain variable region gene PCR system, A9 mouse antibody heavy chain variable region gene PCR system, A10 mouse antibody heavy chain variable region gene PCR system, A11 mouse antibody heavy chain variable region gene PCR system, A12 mouse antibody heavy chain variable region gene PCR system, A13 mouse antibody heavy chain variable region gene PCR system, A14 mouse antibody heavy chain variable region gene PCR system, A15 mouse antibody heavy chain variable Region gene PCR system, A16 mouse antibody heavy chain variable region gene PCR system, A17 mouse antibody heavy chain variable region gene PCR system, A18 mouse antibody heavy chain variable region gene PCR system, A19 mouse antibody heavy chain Variable region gene PCR system, A20 mouse antibody heavy chain variable region gene PCR system, A21 mouse antibody heavy chain variable region gene PCR system, A22 mouse antibody heavy chain variable region gene PCR system, A23 mouse antibody Heavy chain variable region gene PCR system, A24 mouse antibody heavy chain variable region gene PCR system, A25 mouse antibody heavy chain variable region gene PCR system, A26 mouse antibody heavy chain variable region gene PCR system, A27 small Mouse antibody heavy chain variable region gene PCR system, A28 mouse antibody heavy chain variable region gene PCR system, A29 mouse antibody heavy chain variable region gene PCR system, A30 mouse antibody heavy chain variable region gene PCR system, A31 mouse antibody heavy chain variable region gene PCR system, A32 mouse antibody heavy chain variable region gene PCR system, A33 mouse antibody heavy chain variable region gene PCR system, A34 mouse antibody heavy chain variable region gene PCR system.
这29个PCR体系的上游引物均为HM mix;这29个PCR体系的cDNA和下游index引物均不同,其中:A6小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A6的cDNA,下游index引物含有的Barcode序列为B6、5’-CGAAGGTT-3’,A7小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A7的cDNA,下游index引物含有的Barcode序列为B7、5’-CACGCATT-3’,A8小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A8的cDNA,下游index引物含有的Barcode序列为B8、5’-TACCAGGT-3’,A9小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A9的cDNA,下游index引物含有的Barcode序列为B9、5’-TTACCGAG-3’,A10小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A10的cDNA,下游index引物含有的Barcode序列为B10、5’-AGTCACCT-3’,A11小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A11的cDNA,下游index引物含有的Barcode序列为B11、5’-TCGCATTC-3’,A12小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A12的cDNA,下游index引物含有的Barcode序列为B12、5’-CATGGTAC-3’,A13小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A13的cDNA,下游index引物含有的Barcode序列为B13、5’-CACGGACT-3’,A14小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A14的cDNA,下游index引物含有的Barcode序列为B14、5’-CTGTAGCA-3’,A15小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A15的cDNA,下游index引物含有的Barcode序列为B15、5’-AGAGCTTG-3’,A16小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A16的cDNA,下游index引物含有的Barcode序列为B16、5’-AGCATAGC-3’,A17小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A17的cDNA,下游index引物含有的Barcode序列为B17、5’-CCTACCAT-3’,A18小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A18的cDNA,下游index引物含有的Barcode序列为B18、5’-GTCGTTGA-3’,A19小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A19的cDNA,下游index引物含有的Barcode序列为B19、5’-TGCGTATC-3’,A20小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A20的cDNA,下游index引物含有的Barcode序列为B20、5’-AGCTAACC-3’,A21小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A21的cDNA,下游index引物含有的Barcode序列为B21、5’-GAACGGTA-3’,A22小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A22的cDNA,下游index引物含有的Barcode序列为B22、5’-GGATTGTC-3’,A23小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A23的cDNA,下游index引物含有的Barcode序列为B23、5’-TACCGTCT-3’,A24小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A24的cDNA,下游index引物含有的Barcode序列为B24、5’-CGAGTATC-3’,A25小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A25的cDNA,下游index引物含有的Barcode序列为B25、5’-TGTACGCT-3’,A16小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A26的cDNA,下游index引物含有的Barcode序列为B26、5’-TCCTCTGA-3’,A27小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A27的cDNA,下游index引物含有的Barcode序列为B27、5’-AGCGTATC-3’,A28小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A28的cDNA,下游index引物含有的Barcode序列为B28、5’-TCATCACC-3’,A29小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A29的cDNA,下游index引物含有的Barcode序列为B29、5’-GACAGTAC-3’,A30小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A30的cDNA,下游index引物含有的Barcode序列为B30、5’-GTCCTTAC-3’,A31小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A31的cDNA,下游index引物含有的Barcode序列为B31、5’-GGAGCAAT-3’,A32小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A32的cDNA,下游index引物含有的Barcode序列为B32、5’-AGGAACAG-3’,A33小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A33的cDNA,下游index引物含有的Barcode序列为B33、5’-CAGTGCTA-3’,A34小鼠抗体重链可变区PCR体系中的cDNA为杂交瘤细胞A34的cDNA,下游index引物含有的Barcode序列为B34、5’-CTAGCTAG-3’。The upstream primers of these 29 PCR systems are all HM mix; the cDNA and downstream index primers of these 29 PCR systems are different, among which: the cDNA in the A6 mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A6 , the Barcode sequence contained in the downstream index primer is B6, 5'-CGAAGGTT-3', the cDNA in the A7 mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A7, and the Barcode sequence contained in the downstream index primer is B7 , 5'-CACGCATT-3', A8 The cDNA in the mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A8, and the Barcode sequence contained in the downstream index primer is B8, 5'-TACCAGGT-3', A9 The cDNA in the mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A9. The Barcode sequence contained in the downstream index primer is B9, 5'-TTACCGAG-3', and the A10 mouse antibody heavy chain variable region PCR system The cDNA in is the cDNA of hybridoma cell A10. The Barcode sequence contained in the downstream index primer is B10, 5'-AGTCACCT-3'. The cDNA in the A11 mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A11. , the Barcode sequence contained in the downstream index primer is B11, 5'-TCGCATTC-3', the cDNA in the A12 mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A12, and the Barcode sequence contained in the downstream index primer is B12 , 5'-CATGGTAC-3', A13 The cDNA in the mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A13, and the Barcode sequence contained in the downstream index primer is B13, 5'-CACGGACT-3', A14 The cDNA in the mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A14. The Barcode sequence contained in the downstream index primer is B14, 5'-CTGTAGCA-3', and the A15 mouse antibody heavy chain variable region PCR system The cDNA in is the cDNA of hybridoma cell A15. The Barcode sequence contained in the downstream index primer is B15, 5'-AGAGCTTG-3'. The cDNA in the A16 mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A16. , the Barcode sequence contained in the downstream index primer is B16, 5'-AGCATAGC-3', the cDNA in the A17 mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A17, and the Barcode sequence contained in the downstream index primer is B17 , 5'-CCTACCAT-3', A18 mouse antibody heavy chain variable region cDNA in the PCR system is the cDNA of hybridoma cell A18, and the Barcode sequence contained in the downstream index primer is B18, 5'-GTCGTTGA-3', A19 The cDNA in the mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A19. The Barcode sequence contained in the downstream index primer is B19, 5'-TGCGTATC-3', and the A20 mouse antibody heavy chain variable region PCR system The cDNA in is the cDNA of hybridoma cell A20. The Barcode sequence contained in the downstream index primer is B20, 5'-AGCTAACC-3'. The cDNA in the A21 mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A21. , the Barcode sequence contained in the downstream index primer is B21, 5'-GAACGGTA-3', the cDNA in the A22 mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A22, and the Barcode sequence contained in the downstream index primer is B22 , 5'-GGATTGTC-3', A23 The cDNA in the mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A23, and the Barcode sequence contained in the downstream index primer is B23, 5'-TACCGTCT-3', A24 The cDNA in the mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A24. The Barcode sequence contained in the downstream index primer is B24, 5'-CGAGTATC-3', and the A25 mouse antibody heavy chain variable region PCR system The cDNA in is the cDNA of hybridoma cell A25. The Barcode sequence contained in the downstream index primer is B25, 5'-TGTACGCT-3'. The cDNA in the A16 mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A26. , the Barcode sequence contained in the downstream index primer is B26, 5'-TCCTCTGA-3', the cDNA in the A27 mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A27, and the Barcode sequence contained in the downstream index primer is B27 , 5'-AGCGTATC-3', A28 mouse antibody heavy chain variable region cDNA in the PCR system is the cDNA of hybridoma cell A28, and the Barcode sequence contained in the downstream index primer is B28, 5'-TCATCACC-3', A29 The cDNA in the mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A29. The Barcode sequence contained in the downstream index primer is B29, 5'-GACAGTAC-3', and the A30 mouse antibody heavy chain variable region PCR system The cDNA in is the cDNA of hybridoma cell A30. The Barcode sequence contained in the downstream index primer is B30 and 5'-GTCCTTAC-3'. The cDNA in the A31 mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A31. , the Barcode sequence contained in the downstream index primer is B31, 5'-GGAGCAAT-3', the cDNA in the A32 mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A32, and the Barcode sequence contained in the downstream index primer is B32 , 5'-AGGAACAG-3', A33 The cDNA in the mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A33, and the Barcode sequence contained in the downstream index primer is B33, 5'-CAGTGCTA-3', A34 The cDNA in the mouse antibody heavy chain variable region PCR system is the cDNA of hybridoma cell A34, and the Barcode sequence contained in the downstream index primer is B34, 5'-CTAGCTAG-3'.
小鼠抗体重链可变区基因PCR体系:步骤1中A6-A34杂交瘤细胞中的1种杂交瘤细胞的cDNA 1μL,小鼠抗体重链上游引物(HM mix)1μL,下游index引物(含有特异性的Barcode序列与不同杂交瘤细胞的cDNA一一对应)1μL,2×Trans Taq HiFi PCR Super MixⅡ 5μL,ddH2O 2μL,总体积为10μL。Mouse antibody heavy chain variable region gene PCR system: 1 μL of cDNA from one of the A6-A34 hybridoma cells in step 1, 1 μL of mouse antibody heavy chain upstream primer (HM mix), and downstream index primer (containing The specific Barcode sequence corresponds to the cDNA of different hybridoma cells one-to-one) 1 μL, 2×Trans Taq HiFi PCR Super MixⅡ 5 μL, ddH 2 O 2 μL, the total volume is 10 μL.
B、抗体轻链可变区基因PCR体系:B. Antibody light chain variable region gene PCR system:
大鼠抗体轻链可变区PCR体系和小鼠抗体轻链可变区PCR体系的区别仅在于:cDNA模板、上游引物和下游index引物不同,其余均相同。The only difference between the rat antibody light chain variable region PCR system and the mouse antibody light chain variable region PCR system is that the cDNA template, upstream primer and downstream index primer are different, and the rest are the same.
大鼠抗体轻链可变区基因PCR体系共5个PCR体系,这5个PCR体系分别命名为A1大鼠抗体轻链可变区基因PCR体系、A2大鼠抗体轻链可变区基因PCR体系、A3大鼠抗体轻链可变区基因PCR体系、A4大鼠抗体轻链可变区基因PCR体系和A5大鼠抗体轻链可变区基因PCR体系。这5个PCR体系的上游引物均为LR mix;这5个PCR体系的cDNA和下游index引物均不同,其中:A1大鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A1的cDNA,下游index引物含有的Barcode序列为B35、5’-TGCAAGCA-3’,A2大鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A2的cDNA,下游index引物含有的Barcode序列为B36、5’-CGCATCTA-3’,A3大鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A3的cDNA,下游index引物含有的Barcode序列为B37、5’-CGTATCTG-3’,A4大鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A4的cDNA,下游index引物含有的Barcode序列为B38、5’-GTAGACCT-3’,A5大鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A5的cDNA,下游index引物含有的Barcode序列为B39、5’-CGCCATTA-3’。The rat antibody light chain variable region gene PCR system has a total of 5 PCR systems. These 5 PCR systems are named A1 rat antibody light chain variable region gene PCR system and A2 rat antibody light chain variable region gene PCR system. , A3 rat antibody light chain variable region gene PCR system, A4 rat antibody light chain variable region gene PCR system and A5 rat antibody light chain variable region gene PCR system. The upstream primers of these five PCR systems are all LR mix; the cDNA and downstream index primers of these five PCR systems are all different, among which: the cDNA in the A1 rat antibody light chain variable region PCR system is the cDNA of hybridoma cell A1 , the Barcode sequence contained in the downstream index primer is B35, 5'-TGCAAGCA-3', the cDNA in the A2 rat antibody light chain variable region PCR system is the cDNA of hybridoma cell A2, and the Barcode sequence contained in the downstream index primer is B36 , 5'-CGCATCTA-3', A3 The cDNA in the rat antibody light chain variable region PCR system is the cDNA of hybridoma cell A3, and the Barcode sequence contained in the downstream index primer is B37, 5'-CGTATCTG-3', A4 The cDNA in the rat antibody light chain variable region PCR system is the cDNA of hybridoma cell A4. The Barcode sequence contained in the downstream index primer is B38, 5'-GTAGACCT-3', and the A5 rat antibody light chain variable region PCR system The cDNA in is the cDNA of hybridoma cell A5, and the Barcode sequence contained in the downstream index primer is B39, 5'-CGCCATTA-3'.
大鼠抗体轻链可变区基因PCR体系:步骤1中A1-A5杂交瘤细胞中的1种杂交瘤细胞的cDNA 1μL,大鼠抗体轻链上游引物(LR mix)1μL,下游index引物(含有特异性的Barcode序列与不同杂交瘤细胞的cDNA一一对应)1μL,2×Trans Taq HiFi PCR Super Mix Ⅱ 5μL,ddH2O 2μL,总体积为10μL。Rat antibody light chain variable region gene PCR system: 1 μL of cDNA from one of the A1-A5 hybridoma cells in step 1, 1 μL of rat antibody light chain upstream primer (LR mix), and downstream index primer (containing The specific Barcode sequence corresponds to the cDNA of different hybridoma cells one-to-one) 1 μL, 2×Trans Taq HiFi PCR Super Mix II 5 μL, ddH 2 O 2 μL, the total volume is 10 μL.
小鼠抗体轻链可变区基因PCR体系共29个PCR体系,这5个PCR体系分别命名为A6小鼠抗体轻链可变区基因PCR体系、A7小鼠抗体轻链可变区基因PCR体系、A8小鼠抗体轻链可变区基因PCR体系、A9小鼠抗体轻链可变区基因PCR体系、A10小鼠抗体轻链可变区基因PCR体系、A11小鼠抗体轻链可变区基因PCR体系、A12小鼠抗体轻链可变区基因PCR体系、A13小鼠抗体轻链可变区基因PCR体系、A14小鼠抗体轻链可变区基因PCR体系、A15小鼠抗体轻链可变区基因PCR体系、A16小鼠抗体轻链可变区基因PCR体系、A17小鼠抗体轻链可变区基因PCR体系、A18小鼠抗体轻链可变区基因PCR体系、A19小鼠抗体轻链可变区基因PCR体系、A20小鼠抗体轻链可变区基因PCR体系、A21小鼠抗体轻链可变区基因PCR体系、A22小鼠抗体轻链可变区基因PCR体系、A23小鼠抗体轻链可变区基因PCR体系、A24小鼠抗体轻链可变区基因PCR体系、A25小鼠抗体轻链可变区基因PCR体系、A26小鼠抗体轻链可变区基因PCR体系、A27小鼠抗体轻链可变区基因PCR体系、A28小鼠抗体轻链可变区基因PCR体系、A29小鼠抗体轻链可变区基因PCR体系、A30小鼠抗体轻链可变区基因PCR体系、A31小鼠抗体轻链可变区基因PCR体系、A32小鼠抗体轻链可变区基因PCR体系、A33小鼠抗体轻链可变区基因PCR体系、A34小鼠抗体轻链可变区基因PCR体系。The mouse antibody light chain variable region gene PCR system has a total of 29 PCR systems. These 5 PCR systems are named A6 mouse antibody light chain variable region gene PCR system and A7 mouse antibody light chain variable region gene PCR system. , A8 mouse antibody light chain variable region gene PCR system, A9 mouse antibody light chain variable region gene PCR system, A10 mouse antibody light chain variable region gene PCR system, A11 mouse antibody light chain variable region gene PCR system, A12 mouse antibody light chain variable region gene PCR system, A13 mouse antibody light chain variable region gene PCR system, A14 mouse antibody light chain variable region gene PCR system, A15 mouse antibody light chain variable Region gene PCR system, A16 mouse antibody light chain variable region gene PCR system, A17 mouse antibody light chain variable region gene PCR system, A18 mouse antibody light chain variable region gene PCR system, A19 mouse antibody light chain Variable region gene PCR system, A20 mouse antibody light chain variable region gene PCR system, A21 mouse antibody light chain variable region gene PCR system, A22 mouse antibody light chain variable region gene PCR system, A23 mouse antibody Light chain variable region gene PCR system, A24 mouse antibody light chain variable region gene PCR system, A25 mouse antibody light chain variable region gene PCR system, A26 mouse antibody light chain variable region gene PCR system, A27 small Mouse antibody light chain variable region gene PCR system, A28 mouse antibody light chain variable region gene PCR system, A29 mouse antibody light chain variable region gene PCR system, A30 mouse antibody light chain variable region gene PCR system, A31 mouse antibody light chain variable region gene PCR system, A32 mouse antibody light chain variable region gene PCR system, A33 mouse antibody light chain variable region gene PCR system, A34 mouse antibody light chain variable region gene PCR system system.
这29个PCR体系的上游引物均为LM mix;这29个PCR体系的cDNA和下游index引物均不同,其中:A6小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A6的cDNA,下游index引物含有的Barcode序列为B40、5’-ATGACACC-3’,A7小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A7的cDNA,下游index引物含有的Barcode序列为B41、5’-CAAGTTGA-3’,A8小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A8的cDNA,下游index引物含有的Barcode序列为B42、5’-TGCTGAAG-3’,A9小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A9的cDNA,下游index引物含有的Barcode序列为B43、5’-ATGACCGT-3’,A10小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A10的cDNA,下游index引物含有的Barcode序列为B44、5’-TGGCGAGA-3’,A11小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A11的cDNA,下游index引物含有的Barcode序列为B45、5’-GCACTTCC-3’,A12小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A12的cDNA,下游index引物含有的Barcode序列为B46、5’-GTTACCGA-3’,A13小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A13的cDNA,下游index引物含有的Barcode序列为B47、5’-GACGTCAC-3’,A14小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A14的cDNA,下游index引物含有的Barcode序列为B48、5’-GTTACAGC-3’,A15小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A15的cDNA,下游index引物含有的Barcode序列为B49、5’-TCGATTGC-3’,A16小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A16的cDNA,下游index引物含有的Barcode序列为B50、5’-GACGATCT-3’,A17小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A17的cDNA,下游index引物含有的Barcode序列为B51、5’-TGACGCTA-3’,A18小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A18的cDNA,下游index引物含有的Barcode序列为B52、5’-ATAACGCG-3’,A19小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A19的cDNA,下游index引物含有的Barcode序列为B53、5’-GATTCACC-3’,A20小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A20的cDNA,下游index引物含有的Barcode序列为B54、5’-GGCAAGTA-3’,A21小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A21的cDNA,下游index引物含有的Barcode序列为B55、5’-GATCTAGC-3’,A22小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A22的cDNA,下游index引物含有的Barcode序列为B56、5’-CATTGCGA-3’,A23小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A23的cDNA,下游index引物含有的Barcode序列为B57、5’-GCTGTACA-3’,A24小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A24的cDNA,下游index引物含有的Barcode序列为B58、5’-TAGCAGCT-3’,A25小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A25的cDNA,下游index引物含有的Barcode序列为B59、5’-AGCGACAT-3’,A26小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A26的cDNA,下游index引物含有的Barcode序列为B60、5’-CATTAGCC-3’,A27小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A27的cDNA,下游index引物含有的Barcode序列为B61、5’-CATCTCCA-3’,A28小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A28的cDNA,下游index引物含有的Barcode序列为B62、5’-GTCATCGT-3’,A29小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A29的cDNA,下游index引物含有的Barcode序列为B63、5’-GGACTTCA-3’,A30小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A30的cDNA,下游index引物含有的Barcode序列为B64、5’-CAGGATCA-3’,A31小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A31的cDNA,下游index引物含有的Barcode序列为B65、5’-GAACGATG-3’,A32小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A32的cDNA,下游index引物含有的Barcode序列为B66、5’-CGACTTGC-3’,A33小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A33的cDNA,下游index引物含有的Barcode序列为B67、5’-GATTCCGT-3’,A34小鼠抗体轻链可变区PCR体系中的cDNA为杂交瘤细胞A34的cDNA,下游index引物含有的Barcode序列为B68、5’-CCGCTTAC-3’。The upstream primers of these 29 PCR systems are all LM mix; the cDNA and downstream index primers of these 29 PCR systems are different, among which: the cDNA in the A6 mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A6 , the Barcode sequence contained in the downstream index primer is B40, 5'-ATGACACC-3', the cDNA in the A7 mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A7, and the Barcode sequence contained in the downstream index primer is B41 , 5'-CAAGTTGA-3', A8 The cDNA in the mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A8, and the Barcode sequence contained in the downstream index primer is B42, 5'-TGCTGAAG-3', A9 The cDNA in the mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A9. The Barcode sequence contained in the downstream index primer is B43, 5'-ATGACCGT-3', and the A10 mouse antibody light chain variable region PCR system The cDNA in is the cDNA of hybridoma cell A10. The Barcode sequence contained in the downstream index primer is B44, 5'-TGGCGAGA-3'. The cDNA in the A11 mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A11. , the Barcode sequence contained in the downstream index primer is B45, 5'-GCACTTCC-3', the cDNA in the A12 mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A12, and the Barcode sequence contained in the downstream index primer is B46 , 5'-GTTACCGA-3', A13 mouse antibody light chain variable region cDNA in the PCR system is the cDNA of hybridoma cell A13, and the Barcode sequence contained in the downstream index primer is B47, 5'-GACGTCAC-3', A14 The cDNA in the mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A14. The Barcode sequence contained in the downstream index primer is B48, 5'-GTTACAGC-3', and the A15 mouse antibody light chain variable region PCR system The cDNA in is the cDNA of hybridoma cell A15. The Barcode sequence contained in the downstream index primer is B49, 5'-TCGATTGC-3'. The cDNA in the A16 mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A16. , the Barcode sequence contained in the downstream index primer is B50, 5'-GACGATCT-3', the cDNA in the A17 mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A17, and the Barcode sequence contained in the downstream index primer is B51 , 5'-TGACGCTA-3', A18 The cDNA in the mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A18, and the Barcode sequence contained in the downstream index primer is B52, 5'-ATAACGCG-3', A19 The cDNA in the mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A19. The Barcode sequence contained in the downstream index primer is B53, 5'-GATTCACC-3', and the A20 mouse antibody light chain variable region PCR system The cDNA in is the cDNA of hybridoma cell A20. The Barcode sequence contained in the downstream index primer is B54, 5'-GGCAAGTA-3'. The cDNA in the A21 mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A21. , the Barcode sequence contained in the downstream index primer is B55, 5'-GATCTAGC-3', the cDNA in the A22 mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A22, and the Barcode sequence contained in the downstream index primer is B56 , 5'-CATTGCGA-3', A23 The cDNA in the mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A23, and the Barcode sequence contained in the downstream index primer is B57, 5'-GCTGTACA-3', A24 The cDNA in the mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A24. The Barcode sequence contained in the downstream index primer is B58, 5'-TAGCAGCT-3', and the A25 mouse antibody light chain variable region PCR system The cDNA in is the cDNA of hybridoma cell A25. The Barcode sequence contained in the downstream index primer is B59 and 5'-AGCGACAT-3'. The cDNA in the A26 mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A26. , the Barcode sequence contained in the downstream index primer is B60, 5'-CATTAGCC-3', the cDNA in the A27 mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A27, and the Barcode sequence contained in the downstream index primer is B61 , 5'-CATCTCCA-3', A28 mouse antibody light chain variable region cDNA in the PCR system is the cDNA of hybridoma cell A28, and the Barcode sequence contained in the downstream index primer is B62, 5'-GTCATCGT-3', A29 The cDNA in the mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A29. The Barcode sequence contained in the downstream index primer is B63, 5'-GGACTTCA-3', and the A30 mouse antibody light chain variable region PCR system The cDNA in is the cDNA of hybridoma cell A30. The Barcode sequence contained in the downstream index primer is B64 and 5'-CAGGATCA-3'. The cDNA in the A31 mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A31. , the Barcode sequence contained in the downstream index primer is B65, 5'-GAACGATG-3', the cDNA in the A32 mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A32, and the Barcode sequence contained in the downstream index primer is B66 , 5'-CGACTTGC-3', A33 The cDNA in the mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A33, and the Barcode sequence contained in the downstream index primer is B67, 5'-GATTCCGT-3', A34 The cDNA in the mouse antibody light chain variable region PCR system is the cDNA of hybridoma cell A34, and the Barcode sequence contained in the downstream index primer is B68 and 5'-CCGCTTAC-3'.
小鼠抗体轻链可变区基因PCR体系:步骤1中A6-A34杂交瘤细胞中的1种杂交瘤细胞的cDNA 1μL,小鼠抗体轻链上游引物(LM mix)1μL,下游index引物(含有特异性的Barcode序列与不同杂交瘤细胞的cDNA一一对应)1μL,2×Trans Taq HiFi PCR Super MixⅡ 5μL,ddH2O 2μL,总体积为10μL。Mouse antibody light chain variable region gene PCR system: 1 μL of cDNA from one hybridoma cell in the A6-A34 hybridoma cells in step 1, 1 μL of mouse antibody light chain upstream primer (LM mix), and downstream index primer (containing The specific Barcode sequence corresponds to the cDNA of different hybridoma cells one-to-one) 1 μL, 2×Trans Taq HiFi PCR Super MixⅡ 5 μL, ddH 2 O 2 μL, the total volume is 10 μL.
C、PCR体系反应条件为如下:先94℃预变性5min;然后进行如下30个循环:94℃变性30sec,55℃退火30sec,72℃延伸30sec;再72℃延伸7min,4℃保存。C. The reaction conditions of the PCR system are as follows: pre-denaturation at 94°C for 5 minutes; then 30 cycles as follows: denaturation at 94°C for 30 seconds, annealing at 55°C for 30 seconds, extension at 72°C for 30 seconds; extension at 72°C for 7 minutes, and storage at 4°C.
3)扩增产物检测:取5μL本测序方法步骤2)中获得的PCR产物,用1.5%琼脂糖凝胶电泳检测PCR产物。3) Amplification product detection: Take 5 μL of the PCR product obtained in step 2) of this sequencing method, and use 1.5% agarose gel electrophoresis to detect the PCR product.
4)测序分析:将所有待测抗体的重链可变区基因PCR产物和轻链可变区基因PCR产物混合,使用胶回收试剂盒进行产物回收。回收后产物送诺禾致源进行高通量测序。4) Sequencing analysis: Mix the heavy chain variable region gene PCR products and light chain variable region gene PCR products of all antibodies to be tested, and use a gel recovery kit to recover the products. The recovered products were sent to Novogene for high-throughput sequencing.
5)数据分析:将步骤4)得到的测序结果数据使用公司自行开发的抗体序列分析程序进行分析。抗体序列分析程序流程图见图2。数据分析程序设计思路如下:5) Data analysis: The sequencing result data obtained in step 4) is analyzed using the antibody sequence analysis program developed by the company. The flow chart of the antibody sequence analysis program is shown in Figure 2. The data analysis program design ideas are as follows:
A.抗体序列的基本结构A. Basic structure of antibody sequence
(1)抗体重链从N端到C端是由若干个基因组中的VH序列中的一个,若干个基因组中的DH序列中的一个,若干个基因组中的JH中的一个,通过中间随机生成的Junction1H序列和Junction2H序列连接构成的可变区,构成如下结构VH-Junction1H-DH-Junction2H-JH;(1) The antibody heavy chain from N-terminus to C-terminus is randomly generated by one of the VH sequences in several genomes, one of the DH sequences in several genomes, and one of the JH sequences in several genomes. The variable region formed by connecting the Junction1H sequence and Junction2H sequence forms the following structure VH-Junction1H-DH-Junction2H-JH;
(2)抗体轻链从N端到C端是由若干个基因组中的VL序列中的一个,若干个基因组中的JL中的一个,通过中间随机生成的JunctionL序列连接构成的可变区,构成如下结构VL-JunctionL-JL。(2) The antibody light chain from N-terminus to C-terminus is composed of one of the VL sequences in several genomes, one of the JL sequences in several genomes, and a variable region connected by a randomly generated JunctionL sequence in the middle. The following structure VL-JunctionL-JL.
B.重链序列分析思路B. Heavy chain sequence analysis ideas
(1)建立重链数据库VH,DH,JH;(1) Establish heavy chain databases VH, DH, JH;
(2)C端序列与数据库JH比对,确定JH片段;(2) Compare the C-terminal sequence with the JH database to determine the JH fragment;
(3)N端序列与数据库VH比对,确定VH片段;(3) Compare the N-terminal sequence with the VH database to determine the VH fragment;
(4)移除JH片段与VH片段,余下序列与数据库DH比对,确定DH片段以及两端的随机生成的Junction1H序列以及Junction2H。(4) Remove the JH fragment and VH fragment, compare the remaining sequence with the database DH, and determine the DH fragment and the randomly generated Junction1H sequences and Junction2H at both ends.
C.轻链序列分析思路C. Ideas for light chain sequence analysis
(1)建立轻链数据库VL,JL;(1) Establish light chain database VL, JL;
(2)C端序列与数据库JL比对,确定JL片段;(2) Compare the C-terminal sequence with the JL database to determine the JL fragment;
(3)N端序列与数据库VL比对,确定VL片段;(3) Compare the N-terminal sequence with the VL database to determine the VL fragment;
(4)移除JL片段与VL片段,得到随机生成的JunctionL序列。(4) Remove the JL fragment and VL fragment to obtain a randomly generated JunctionL sequence.
D.追踪重链轻链进化D. Tracking the evolution of heavy and light chains
由于抗体重链和轻链在免疫过程中不断突变,所以可以追踪抗体进化过程。具体步骤如下:Because antibody heavy and light chains continue to mutate during immunity, antibody evolution can be tracked. Specific steps are as follows:
(1)提取具有相同基本结构的重链序列,即具有相同的VH片段,DH片段,JH片段的序列,以无突变的基因组序列为原点,通过ClustalOmega程序建立重链进化树;(1) Extract heavy chain sequences with the same basic structure, that is, sequences with the same VH fragment, DH fragment, and JH fragment, and use the mutation-free genome sequence as the origin to establish a heavy chain evolutionary tree through the ClustalOmega program;
(2)提取具有相同基本结构的轻链序列,即具有相同的VL片段,JL片段的序列,以无突变的基因组序列为原点,通过ClustalOmega程序建立轻链进化树。(2) Extract light chain sequences with the same basic structure, that is, sequences with the same VL fragment and JL fragment, and use the mutation-free genome sequence as the origin to build a light chain evolutionary tree through the ClustalOmega program.
使用含Barcode引物扩增大鼠抗体5个,小鼠抗体29个,结果如图3和图4所示:使用含barcode引物扩增抗体轻链可变区基因和重链可变区基因,PCR产物均在250bp-500bp扩增出条带,条带大小与预测大小一致。Barcode-containing primers were used to amplify 5 rat antibodies and 29 mouse antibodies. The results are shown in Figure 3 and Figure 4: Use barcode-containing primers to amplify the antibody light chain variable region gene and heavy chain variable region gene, PCR The products all amplified bands between 250bp and 500bp, and the band size was consistent with the predicted size.
将含barcode的PCR产物混合,进行二代测序。测序结果使用软件分析得到5个大鼠抗体和29个小鼠抗体的正确轻链和重链可变区基因序列。Mix the barcode-containing PCR products and perform next-generation sequencing. The sequencing results were analyzed using software to obtain the correct light chain and heavy chain variable region gene sequences of 5 rat antibodies and 29 mouse antibodies.
抗体测序结果如下:所有抗体均测序成功。详细测序结果的核苷酸序列见序列表中序列66-序列133。其中:抗体A1的轻链可变区基因序列为序列表中序列66的DNA分子,重链可变区基因序列为序列表中序列67的DNA分子;抗体A2的轻链可变区基因序列为序列表中序列68的DNA分子,重链可变区基因序列为序列表中序列69的DNA分子;抗体A3的轻链可变区基因序列为序列表中序列70的DNA分子,重链可变区基因序列为序列表中序列71的DNA分子;抗体A4的轻链可变区基因序列为序列表中序列72的DNA分子,重链可变区基因序列为序列表中序列73的DNA分子;抗体A5的轻链可变区基因序列为序列表中序列74的DNA分子,重链可变区基因序列为序列表中序列75的DNA分子;抗体A6的轻链可变区基因序列为序列表中序列76的DNA分子,重链可变区基因序列为序列表中序列77的DNA分子;抗体A7的轻链可变区基因序列为序列表中序列78的DNA分子,重链可变区基因序列为序列表中序列79的DNA分子;抗体A8的轻链可变区基因序列为序列表中序列80的DNA分子,重链可变区基因序列为序列表中序列81的DNA分子;抗体A9的轻链可变区基因序列为序列表中序列82的DNA分子,重链可变区基因序列为序列表中序列83的DNA分子;抗体A10的轻链可变区基因序列为序列表中序列84的DNA分子,重链可变区基因序列为序列表中序列85的DNA分子;抗体A11的轻链可变区基因序列为序列表中序列86的DNA分子,重链可变区基因序列为序列表中序列87的DNA分子;抗体A12的轻链可变区基因序列为序列表中序列88的DNA分子,重链可变区基因序列为序列表中序列89的DNA分子;抗体A13的轻链可变区基因序列为序列表中序列90的DNA分子,重链可变区基因序列为序列表中序列91的DNA分子;抗体A14的轻链可变区基因序列为序列表中序列92的DNA分子,重链可变区基因序列为序列表中序列93的DNA分子;抗体A15的轻链可变区基因序列为序列表中序列94的DNA分子,重链可变区基因序列为序列表中序列95的DNA分子;抗体A16的轻链可变区基因序列为序列表中序列96的DNA分子,重链可变区基因序列为序列表中序列97的DNA分子;抗体A17的轻链可变区基因序列为序列表中序列98的DNA分子,重链可变区基因序列为序列表中序列99的DNA分子;抗体A18的轻链可变区基因序列为序列表中序列100的DNA分子,重链可变区基因序列为序列表中序列101的DNA分子;抗体A19的轻链可变区基因序列为序列表中序列102的DNA分子,重链可变区基因序列为序列表中序列103的DNA分子;抗体A20的轻链可变区基因序列为序列表中序列104的DNA分子,重链可变区基因序列为序列表中序列105的DNA分子;抗体A21的轻链可变区基因序列为序列表中序列106的DNA分子,重链可变区基因序列为序列表中序列107的DNA分子;抗体A22的轻链可变区基因序列为序列表中序列108的DNA分子,重链可变区基因序列为序列表中序列109的DNA分子;抗体A23的轻链可变区基因序列为序列表中序列110的DNA分子,重链可变区基因序列为序列表中序列111的DNA分子;抗体A24的轻链可变区基因序列为序列表中序列112的DNA分子,重链可变区基因序列为序列表中序列113的DNA分子;抗体A25的轻链可变区基因序列为序列表中序列114的DNA分子,重链可变区基因序列为序列表中序列115的DNA分子;抗体A26的轻链可变区基因序列为序列表中序列116的DNA分子,重链可变区基因序列为序列表中序列117的DNA分子;抗体A27的轻链可变区基因序列为序列表中序列118的DNA分子,重链可变区基因序列为序列表中序列119的DNA分子;抗体28的轻链可变区基因序列为序列表中序列120的DNA分子,重链可变区基因序列为序列表中序列121的DNA分子;抗体A29的轻链可变区基因序列为序列表中序列122的DNA分子,重链可变区基因序列为序列表中序列123的DNA分子;抗体A30的轻链可变区基因序列为序列表中序列124的DNA分子,重链可变区基因序列为序列表中序列125的DNA分子;抗体A31的轻链可变区基因序列为序列表中序列126的DNA分子,重链可变区基因序列为序列表中序列127的DNA分子;抗体A32的轻链可变区基因序列为序列表中序列128的DNA分子,重链可变区基因序列为序列表中序列129的DNA分子;抗体A33的轻链可变区基因序列为序列表中序列130的DNA分子,重链可变区基因序列为序列表中序列131的DNA分子;抗体A34的轻链可变区基因序列为序列表中序列132的DNA分子,重链可变区基因序列为序列表中序列133的DNA分子。The antibody sequencing results are as follows: all antibodies were sequenced successfully. For the nucleotide sequence of the detailed sequencing results, see Sequence 66 to Sequence 133 in the sequence listing. Among them: the light chain variable region gene sequence of antibody A1 is the DNA molecule of sequence 66 in the sequence listing, and the heavy chain variable region gene sequence is the DNA molecule of sequence 67 in the sequence listing; the light chain variable region gene sequence of antibody A2 is The DNA molecule of sequence 68 in the sequence listing, the heavy chain variable region gene sequence is the DNA molecule of sequence 69 in the sequence listing; the light chain variable region gene sequence of antibody A3 is the DNA molecule of sequence 70 in the sequence listing, and the heavy chain variable region The region gene sequence is the DNA molecule of sequence 71 in the sequence listing; the light chain variable region gene sequence of antibody A4 is the DNA molecule of sequence 72 in the sequence listing, and the heavy chain variable region gene sequence is the DNA molecule of sequence 73 in the sequence listing; The light chain variable region gene sequence of antibody A5 is the DNA molecule of sequence 74 in the sequence list, and the heavy chain variable region gene sequence is the DNA molecule of sequence 75 in the sequence list; the light chain variable region gene sequence of antibody A6 is the sequence list. The DNA molecule of sequence 76, the heavy chain variable region gene sequence is the DNA molecule of sequence 77 in the sequence list; the light chain variable region gene sequence of antibody A7 is the DNA molecule of sequence 78 in the sequence list, and the heavy chain variable region gene The sequence is the DNA molecule of sequence 79 in the sequence listing; the light chain variable region gene sequence of antibody A8 is the DNA molecule of sequence 80 in the sequence listing, and the heavy chain variable region gene sequence is the DNA molecule of sequence 81 in the sequence listing; antibody A9 The light chain variable region gene sequence is the DNA molecule of sequence 82 in the sequence listing, and the heavy chain variable region gene sequence is the DNA molecule of sequence 83 in the sequence listing; the light chain variable region gene sequence of antibody A10 is the sequence in the sequence listing The DNA molecule of 84, the heavy chain variable region gene sequence is the DNA molecule of sequence 85 in the sequence listing; the light chain variable region gene sequence of antibody A11 is the DNA molecule of sequence 86 in the sequence listing, and the heavy chain variable region gene sequence is The DNA molecule of sequence 87 in the sequence listing; the light chain variable region gene sequence of antibody A12 is the DNA molecule of sequence 88 in the sequence listing, and the heavy chain variable region gene sequence is the DNA molecule of sequence 89 in the sequence listing; the light chain variable region gene sequence of antibody A13 The gene sequence of the chain variable region is the DNA molecule of sequence 90 in the sequence listing, and the gene sequence of the heavy chain variable region is the DNA molecule of sequence 91 in the sequence listing; the light chain variable region gene sequence of antibody A14 is the DNA molecule of sequence 92 in the sequence listing. DNA molecule, the heavy chain variable region gene sequence is the DNA molecule with sequence 93 in the sequence listing; the light chain variable region gene sequence of antibody A15 is the DNA molecule with sequence 94 in the sequence listing, and the heavy chain variable region gene sequence is the sequence listing The DNA molecule of sequence 95 in the sequence list; the light chain variable region gene sequence of antibody A16 is the DNA molecule of sequence 96 in the sequence listing, and the heavy chain variable region gene sequence is the DNA molecule of sequence 97 in the sequence listing; the light chain of antibody A17 can be The variable region gene sequence is the DNA molecule with sequence 98 in the sequence list, the heavy chain variable region gene sequence is the DNA molecule with sequence 99 in the sequence list; the light chain variable region gene sequence of antibody A18 is the DNA molecule with sequence 100 in the sequence list , the heavy chain variable region gene sequence is the DNA molecule of sequence 101 in the sequence listing; the light chain variable region gene sequence of antibody A19 is the DNA molecule of sequence 102 in the sequence listing, and the heavy chain variable region gene sequence is the sequence in the sequence listing The DNA molecule of 103; the light chain variable region gene sequence of antibody A20 is the DNA molecule of sequence 104 in the sequence listing; the heavy chain variable region gene sequence is the DNA molecule of sequence 105 in the sequence listing; the light chain variable region of antibody A21 The gene sequence is the DNA molecule of sequence 106 in the sequence listing, and the heavy chain variable region gene sequence is the DNA molecule of sequence 107 in the sequence listing; the light chain variable region gene sequence of antibody A22 is the DNA molecule of sequence 108 in the sequence listing, and the heavy chain variable region gene sequence is the DNA molecule of sequence 107 in the sequence listing. The gene sequence of the chain variable region is the DNA molecule of sequence 109 in the sequence list; the gene sequence of the light chain variable region of antibody A23 is the DNA molecule of sequence 110 in the sequence list, and the gene sequence of the heavy chain variable region is the DNA molecule of sequence 111 in the sequence list. DNA molecule; the light chain variable region gene sequence of antibody A24 is the DNA molecule with sequence 112 in the sequence listing, and the heavy chain variable region gene sequence is the DNA molecule with sequence 113 in the sequence listing; the light chain variable region gene sequence of antibody A25 is the DNA molecule with sequence 114 in the sequence listing, and the heavy chain variable region gene sequence is the DNA molecule with sequence 115 in the sequence listing; the light chain variable region gene sequence of antibody A26 is the DNA molecule with sequence 116 in the sequence listing, and the heavy chain can be The variable region gene sequence is the DNA molecule of sequence 117 in the sequence list; the light chain variable region gene sequence of antibody A27 is the DNA molecule of sequence 118 in the sequence list, and the heavy chain variable region gene sequence is the DNA molecule of sequence 119 in the sequence list. ; The light chain variable region gene sequence of antibody 28 is the DNA molecule of sequence 120 in the sequence listing, and the heavy chain variable region gene sequence is the DNA molecule of sequence 121 in the sequence listing; the light chain variable region gene sequence of antibody A29 is sequence The DNA molecule of sequence 122 in the list, the heavy chain variable region gene sequence is the DNA molecule of sequence 123 in the sequence listing; the light chain variable region gene sequence of antibody A30 is the DNA molecule of sequence 124 in the sequence listing, and the heavy chain variable region The gene sequence is the DNA molecule of sequence 125 in the sequence listing; the light chain variable region gene sequence of antibody A31 is the DNA molecule of sequence 126 in the sequence listing, and the heavy chain variable region gene sequence is the DNA molecule of sequence 127 in the sequence listing; the antibody The light chain variable region gene sequence of A32 is the DNA molecule with sequence 128 in the sequence listing, and the heavy chain variable region gene sequence is the DNA molecule with sequence 129 in the sequence listing; the light chain variable region gene sequence of antibody A33 is the DNA molecule in sequence listing The DNA molecule of sequence 130, the heavy chain variable region gene sequence is the DNA molecule of sequence 131 in the sequence listing; the light chain variable region gene sequence of antibody A34 is the DNA molecule of sequence 132 in the sequence listing, and the heavy chain variable region gene sequence It is the DNA molecule of sequence 133 in the sequence listing.
以上对本发明进行了详述。对于本领域技术人员来说,在不脱离本发明的宗旨和范围,以及无需进行不必要的实验情况下,可在等同参数、浓度和条件下,在较宽范围内实施本发明。虽然本发明给出了特殊的实施例,应该理解为,可以对本发明作进一步的改进。总之,按本发明的原理,本申请欲包括任何变更、用途或对本发明的改进,包括脱离了本申请中已公开范围,而用本领域已知的常规技术进行的改变。The present invention has been described in detail above. For those skilled in the art, the present invention can be implemented in a wider range under equivalent parameters, concentrations and conditions without departing from the spirit and scope of the invention and without performing unnecessary experiments. Although specific embodiments of the present invention have been shown, it should be understood that further modifications can be made to the invention. In short, based on the principles of the present invention, this application is intended to include any changes, uses, or improvements to the present invention, including changes that depart from the scope disclosed in this application and are made using conventional techniques known in the art.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311283506.3A CN117004700A (en) | 2023-10-07 | 2023-10-07 | Method for high-throughput sequencing of monoclonal antibody variable region genes, composition and kit used by method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311283506.3A CN117004700A (en) | 2023-10-07 | 2023-10-07 | Method for high-throughput sequencing of monoclonal antibody variable region genes, composition and kit used by method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117004700A true CN117004700A (en) | 2023-11-07 |
Family
ID=88569474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311283506.3A Pending CN117004700A (en) | 2023-10-07 | 2023-10-07 | Method for high-throughput sequencing of monoclonal antibody variable region genes, composition and kit used by method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117004700A (en) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104017079A (en) * | 2007-08-29 | 2014-09-03 | 塞诺菲-安万特股份有限公司 | Humanized anti-CXCR5 antibodies, derivatives thereof and uses thereof |
| CN104271757A (en) * | 2012-02-06 | 2015-01-07 | 印希彼有限责任公司 | Cd47 antibodies and methods of use thereof |
| CN105039322A (en) * | 2015-07-01 | 2015-11-11 | 益善生物技术股份有限公司 | DNA label sequence, sequencing library construction method and kit |
| WO2016031936A1 (en) * | 2014-08-29 | 2016-03-03 | 国立大学法人北海道大学 | Monoclonal antibody against kir2ds1 |
| CN106065031A (en) * | 2016-01-14 | 2016-11-02 | 苏州金唯智生物科技有限公司 | Antibody based on hybridoma technology and high-flux sequence finds method |
| CN106191045A (en) * | 2016-08-08 | 2016-12-07 | 中国科学院北京基因组研究所 | Index and primer for multiple nucleic acid order-checking |
| CN108165620A (en) * | 2018-01-05 | 2018-06-15 | 东莞博奥木华基因科技有限公司 | Label and its preparation method and application |
| US20190255173A1 (en) * | 2016-07-05 | 2019-08-22 | Sanofi | Antibody formulations |
| US20200181246A1 (en) * | 2017-06-29 | 2020-06-11 | The Trustees Of Columbia University In The City Of New York | Chimeric antibodies for treatment of amyloid deposition diseases |
| CN111575349A (en) * | 2020-05-27 | 2020-08-25 | 东莞博奥木华基因科技有限公司 | Linker sequence and application thereof |
-
2023
- 2023-10-07 CN CN202311283506.3A patent/CN117004700A/en active Pending
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104017079A (en) * | 2007-08-29 | 2014-09-03 | 塞诺菲-安万特股份有限公司 | Humanized anti-CXCR5 antibodies, derivatives thereof and uses thereof |
| CN104271757A (en) * | 2012-02-06 | 2015-01-07 | 印希彼有限责任公司 | Cd47 antibodies and methods of use thereof |
| WO2016031936A1 (en) * | 2014-08-29 | 2016-03-03 | 国立大学法人北海道大学 | Monoclonal antibody against kir2ds1 |
| EP3187583A1 (en) * | 2014-08-29 | 2017-07-05 | National University Corporation Hokkaido University | Monoclonal antibody against kir2ds1 |
| CN105039322A (en) * | 2015-07-01 | 2015-11-11 | 益善生物技术股份有限公司 | DNA label sequence, sequencing library construction method and kit |
| CN106065031A (en) * | 2016-01-14 | 2016-11-02 | 苏州金唯智生物科技有限公司 | Antibody based on hybridoma technology and high-flux sequence finds method |
| US20190255173A1 (en) * | 2016-07-05 | 2019-08-22 | Sanofi | Antibody formulations |
| CN106191045A (en) * | 2016-08-08 | 2016-12-07 | 中国科学院北京基因组研究所 | Index and primer for multiple nucleic acid order-checking |
| US20200181246A1 (en) * | 2017-06-29 | 2020-06-11 | The Trustees Of Columbia University In The City Of New York | Chimeric antibodies for treatment of amyloid deposition diseases |
| CN108165620A (en) * | 2018-01-05 | 2018-06-15 | 东莞博奥木华基因科技有限公司 | Label and its preparation method and application |
| CN111575349A (en) * | 2020-05-27 | 2020-08-25 | 东莞博奥木华基因科技有限公司 | Linker sequence and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| 刘宏德等: "生物数据分析与实践", vol. 1, 南京:东南大学出版社, pages: 50 - 72 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106192018A (en) | A kind of method of grappling Nest multiplex PCR enrichment DNA target area and test kit | |
| CN105238859B (en) | A kind of method for obtaining chicken full-length genome high density SNP marker site | |
| CN107075731A (en) | Method and reagent for constructing nucleic acid single-stranded circular library | |
| CN104032377A (en) | Construction method of single cell transcriptome sequencing library and application of construction method | |
| CN102181533A (en) | Multi-sample mixed sequencing method and kit | |
| CN110878334B (en) | Primers for amplicon sequencing and two-step PCR library construction method | |
| CN111808854A (en) | Equilibrium linker with molecular barcode and method for rapid construction of transcriptome library | |
| CN107829146A (en) | Primer group for constructing 16SrRNA gene amplicon sequencing library and construction method | |
| CN102409043B (en) | Method for constructing high-flux and low-cost Fosmid library, label and label joint used in method | |
| CN111379031A (en) | Nucleic acid library construction method, obtained nucleic acid library and use thereof | |
| CN105506063A (en) | Primer composition and uses thereof | |
| JP6904953B2 (en) | How to determine cell clonality | |
| CN111748637A (en) | A SNP molecular marker combination, multiplex composite amplification primer set, kit and method for kinship analysis and identification | |
| WO2021253372A1 (en) | High-compatibility pcr-free library building and sequencing method | |
| CN105087560B (en) | A kind of multiple PCR primer and method building pig BCR heavy chain library based on high-flux sequence | |
| CN105524920A (en) | TN5 library building primer group for Ion Proton sequencing platform, TN5 library building kit for Ion Proton sequencing platform and library building method | |
| CN104372073B (en) | The reagent of a kind of energy specific detection Mur antigen gene and detection method | |
| CN101948919A (en) | Kit used for paternity test of giant pandas | |
| CN114574569B (en) | Genome sequencing kit and sequencing method based on terminal transferase | |
| CN117004700A (en) | Method for high-throughput sequencing of monoclonal antibody variable region genes, composition and kit used by method | |
| CN114774517A (en) | A method and kit for sequencing human immune repertoire | |
| CN105463093A (en) | Primer, kit and amplification method for fish mitochondria whole genome amplification | |
| CN108707653B (en) | Kit for constructing variable region sequence library and sequencing method of variable region sequence | |
| CN107574245A (en) | Detection in Gene Mutation primer pair, kit and targeting sequencing library construction method | |
| CN108342385A (en) | A kind of connector and the method that sequencing library is built by way of high efficiency cyclisation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20231107 |